Ether lipids influence cancer cell fate by modulating iron uptake 1 2 Whitney S . Henry 1 , Sebastian MÃ¼ller 2 , Jia - Shu Yang 3 , Sarah Innes - Gold 4 , Sunny Das 1 , 3 Ferenc Reinhardt 1 , Kim Sigmund 1 , Vaishnavi V . Phadnis 1 , 5 , Zhengpeng Wan 6 , Elinor 4 Eaton 1 , Julio L . Sampaio 7 , George W . Bell 1 , Amartya Viravalli 8 , Paula T . Hammond 9 , 10 , 15 , 5 Roger D . Kamm 6 , 12 , 15 , Adam E . Cohen 4 , 12 , 15 , Natalie Boehnke 8 , 9 , 15 , Victor W . Hsu 3 , 15 , 6 Kandice R . Levental 13 , 15 , RaphaÃ«l Rodriguez 2 , 15 , * and Robert A . Weinberg 1 , 5 , 14 , 15 , * , # 7 8 1 . Whitehead Institute for Biomedical Research , Cambridge , MA 02142 , USA 9 2 . Institut Curie , CNRS , INSERM , PSL Research University , Equipe LabellisÃ©e 10 Ligue Contre le Cancer , Paris 75005 , France 11 3 . Division of Rheumatology , Inflammation and Immunity , Brigham and Womenâ€™s 12 Hospital , and Dept . of Medicine , Harvard Medical School , Boston , MA 02115 , 13 USA 14 4 . Dept . of Chemistry and Chemical Biology , Harvard University , Cambridge , MA 15 02138 , USA 16 5 . Dept . of Biology , MIT , Cambridge , MA 02139 , USA 17 6 . Dept . of Biological Engineering , MIT , Cambridge , MA 02139 , USA 18 7 . Institut Curie , INSERM , Mines ParisTech , Paris 75005 , France 19 8 . Dept . of Chemical Engineering and Materials Science , University of Minnesota 20 Minneapolis , MN 55455 , USA 21 9 . Koch Institute for Integrative Cancer Research , MIT , Cambridge , MA 02139 , USA 22 10 . Dept . of Chemical Engineering , MIT , Cambridge , MA 02139 , USA 23 11 . Dept . of Mechanical Engineering , MIT , Cambridge , MA 02139 , USA 24 12 . Dept . of Physics , Harvard University , Cambridge , MA 02138 , USA 25 13 . Dept . of Molecular Physiology and Biological Physics , Center for Membrane and 26 Cell Physiology , University of Virginia , Charlottesville , VA 22903 , USA 27 14 . Ludwig Center for Molecular Oncology , Cambridge , MA 02139 , USA 28 15 . Senior author 29 # Lead contact 30 * Correspondence : RaphaÃ«l Rodriguez , PhD ( raphael . rodriguez @ curie . fr ) and Robert 31 A . Weinberg , PhD ( weinberg @ wi . mit . edu ) 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ABSTRACT 47 Cancer cell fate has been widely ascribed to mutational changes within protein - coding 48 genes associated with tumor suppressors and oncogenes . In contrast , the mechanisms 49 through which the biophysical properties of membrane lipids influence cancer cell 50 survival , dedifferentiation and metastasis have received little scrutiny . Here , we report 51 that cancer cells endowed with a high metastatic ability and cancer stem cell - like traits 52 employ ether lipids to maintain low membrane tension and high membrane fluidity . 53 Using genetic approaches and lipid reconstitution assays , we show that these ether 54 lipid - regulated biophysical properties permit non - clathrin - mediated iron endocytosis via 55 CD44 , leading directly to significant increases in intracellular redox - active iron and 56 enhanced ferroptosis susceptibility . Using a combination of in vitro three - dimensional 57 microvascular network systems and in vivo animal models , we show that loss of ether 58 lipids also strongly attenuates extravasation , metastatic burden and cancer stemness . 59 These findings illuminate a mechanism whereby ether lipids in carcinoma cells serve as 60 key regulators of malignant progression while conferring a unique vulnerability that can 61 be exploited for therapeutic intervention . 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 KEYWORDS 91 Ether lipids , membrane tension , endocytosis , CD44 , iron , metastasis , ferroptosis . 92 INTRODUCTION 93 Cancer cells have the capacity to undergo dynamic changes in identity , structure , 94 and function , making them remarkably versatile and adaptable . Alterations in the lipid 95 composition of cell membranes is one key element contributing to the phenotypic 96 plasticity of cells . The distinctive physicochemical properties and subcellular localization 97 of various lipids within cell membranes influence a range of biological processes , 98 including cellular trafficking , signaling and metabolism 1 . Despite our growing knowledge 99 of lipid biology , our understanding of how specific lipid subtypes impact cancer cell fate 100 remains limited . 101 Emerging studies have demonstrated that therapy - resistant mesenchymal - like 102 carcinoma cells exhibit an elevated vulnerability to ferroptosis 2 - 4 , an iron - dependent 103 form of cell death characterized by the unrestricted accumulation of oxidized membrane 104 phospholipids 5 - 7 . Indeed , in previous work we showed that the natural product 105 salinomycin can selectively eliminate otherwise therapy resistant , mesenchymal - 106 enriched cancer stem cells ( CSC ) , doing so by targeting lysosomal iron to promote an 107 iron - dependent cell death 4 , 8 , 9 . In this context , we found that such CSC - enriched cells 108 exhibit a high intracellular iron load compared to their non - CSC - like counterparts , 109 rendering them especially vulnerable to elimination by induced ferroptosis 13 , 14 . 110 Ferroptosis can also be instigated by pharmacologic inhibition of ferroptosis 111 suppressors , such as glutathione peroxidase 4 ( GPX4 ) 5 , 10 , ferroptosis - suppressor 112 protein 1 ( FSP1 , previously known as AIFM2 ) 11 , 12 , as well as through downregulation of 113 reduced glutathione ( GSH ) 13 , 14 . Activated CD8 + T cells may also induce ferroptosis in 114 cancer cells 9 , 10 . Beyond cancer , ferroptosis has been implicated in the pathogenesis of 115 several neurodegenerative diseases and acute injury of the kidney , liver and heart 15 - 18 . 116 In previous work , we undertook an unbiased , genome - wide CRISPR / Cas9 117 screen with the goal of identifying genes that govern ferroptosis susceptibility in high - 118 grade human serous ovarian cancer cells 19 . This screen revealed a previously 119 unrecognized role for ether lipid - synthesizing enzymes , such as alkylglycerone 120 phosphate synthase ( AGPS ) , in modulating ferroptosis susceptibility . The ether 121 phospholipids generated by these enzymes represent a unique subclass of 122 glycerophospholipids characterized by an ether - linked hydrocarbon group formed at the 123 sn - 1 position of the glycerol backbone 20 . This phospholipid subtype constitutes ~ 20 % of 124 the total phospholipid pool in many types of mammalian cells . 125 The significance of ether lipid species in human health is underscored by the 126 severe inherited peroxisomal disorders caused by their deficiency 20 . This often 127 manifests as profound developmental abnormalities , such as neurological defects , 128 visual and hearing loss , and reduced lifespan . In the context of cancer , elevated ether 129 lipid levels have been correlated with increased metastatic potential of carcinoma 130 cells 21 - 24 . Despite these pathological associations , the mechanism ( s ) by which ether 131 lipids affect cancer progression remain ( s ) elusive . Furthermore , exactly why loss of 132 ether lipids results in decreased ferroptosis susceptibility required further investigation . 133 Our previous work and that of others ascribed a role to polyunsaturated ether 134 phospholipids as chemical substrates prone to the iron - mediated oxidation that triggers 135 ferroptotic cell death 19 , 25 . Here , we demonstrate that ether lipids also play an unrelated 136 biophysical role , doing so by facilitating iron endocytosis in carcinoma cells . This 137 represents an unappreciated mechanism of intracellular signaling in which a lipid 138 contributes to the intracellular level of a critical metal - based signaling species - iron . In 139 addition , our findings highlight the functional importance of this poorly studied lipid 140 subtype in enabling a variety of malignancy - associated cell phenotypes including 141 metastasis and tumor - initiating abilities . Together , these results establish a role for ether 142 lipids as critical effectors of cancer cell fate . 143 144 RESULTS 145 Ether lipids play a key role in maintaining a ferroptosis susceptible cell state 146 In order to investigate the mechanism ( s ) by which ether lipid deficiency reduces 147 ferroptosis susceptibility , we employed CRISPR / Cas9 to knockout ( KO ) the AGPS gene , 148 in ferroptosis - sensitive TGF - Î² - treated PyMT - 1099 murine breast cancer cells 26 ( Fig . 1a , 149 1b , Extended Data Fig . 1a ) . The AGPS gene encodes a rate - limiting enzyme critical for 150 ether lipid biosynthesis 20 . Consistent with our prior studies 19 , loss of ether lipids via 151 AGPS KO significantly decreased the susceptibility of these cancer cells to ferroptosis 152 induced by treatment with the GPX4 inhibitors ML210 or RSL3 ( Fig . 1c , Extended Data 153 Fig . 1b ) . 154 By performing lipidomic analysis , we validated that knockout of AGPS resulted in 155 a significant reduction in total ether abundance in these cells ( Fig . 1d ) . More than half of 156 the identified ether lipids contained polyunsaturated fatty acyl groups which are highly 157 prone to free radical attack ( Fig . 1e ) . Based on this observation , we speculated that loss 158 of ether lipids could attenuate ferroptosis susceptibility by depleting the pool of available 159 ether lipid substrates for lipid peroxidation . Therefore , we performed oxidized lipidomic 160 analysis on two ferroptosis - sensitive breast cancer cell lines that were treated with a 161 GPX4 inhibitor . These experiments indicated that ether lipids could indeed be oxidized 162 following ferroptosis induction ( Fig . 1f , Extended Data Fig . 1c ) . 163 Given that ether lipids only constitute about ~ 20 % of total lipids , we also 164 investigated whether the relative abundance of non - ether - linked polyunsaturated 165 phospholipids , were impacted by loss of ether lipids . Surprisingly , our analyses revealed 166 that ether lipid deficiency actually increased the relative abundance of several 167 polyunsaturated diacyl phospholipids with putative pro - ferroptosis function 27 , 28 ( Fig . 1g ) . 168 To ensure that these findings were not an idiosyncrasy of our TGF - Î² - treated PyMT - 1099 169 AGPS KO cells , we confirmed this observation in PyMT - MMTV - derived pB3 murine 170 AGPS KO breast cancer cells 29 ( Fig . 1h , 1i , Extended Data Fig . 1d ) . Importantly , re - 171 expression of AGPS ( i . e . , â€œaddbackâ€ ) could restore the relative levels of these non - 172 ether - linked polyunsaturated diacyl phospholipids to levels comparable to pB3 WT cells 173 ( Fig . 1j ) . These findings strongly argue against the notion that ether deficiency 174 attenuates ferroptosis susceptibility simply by decreasing the global level of 175 polyunsaturated phospholipids and further underscores the importance of 176 polyunsaturated ether phospholipids in maintaining a ferroptosis susceptible cell state . 177 178 Ether lipids regulate cellular redox - active iron levels in cancer cells 179 The above observations together with our oxidized ether phospholipidomic 180 analysis supported the notion that ether lipids could modulate ferroptosis susceptibility , 181 at least in part , by serving as substrates for lipid peroxidation . These observations , 182 however , failed to address the formal possibility that alterations of ether lipid 183 composition could also affect intracellular levels of redox - active iron , the central 184 mediator of the lipid peroxidation that drives ferroptosis . For this reason , we investigated 185 whether alterations in ether lipid composition actually affected the intracellular levels of 186 redox - active iron . To address this possibility , we used two orthogonal analyses to 187 assess intracellular iron levels . Since the endolysosomal compartment is a key reservoir 188 of iron within cells 30 - 32 , we used a lysosomal iron ( II ) - specific fluorescent probe , 189 RhoNox - M 33 , to gauge the levels of iron within these cells . In addition , we used 190 inductively coupled plasma mass spectrometry ( ICP - MS ) to quantify total intracellular 191 iron levels 32 , 34 , 35 . 192 Remarkably , loss of AGPS reduced intracellular iron levels in all murine cancer 193 cell lines tested , whereas re - expression of AGPS ( i . e . , â€œaddbackâ€ ) restored intracellular 194 iron to levels comparable to those seen in parental ferroptosis - sensitive cancer cells 195 ( Fig . 2a - 2d , Extended Data Fig . 2a ) . This provided the first indication that changes in 196 ether phospholipids directly affect the levels of intracellular iron . Indeed , there was no 197 direct precedent for the ability of a membrane - associated phospholipid to serve as an 198 enhancer of the levels of an intracellular metal ion . 199 Supporting this conclusion , we found that a reduction in the levels of ether lipids , 200 achieved via knockout of the genes encoding either the AGPS or the fatty acid 201 reductase 1 ( FAR1 ) enzymes 20 ( Extended Data Fig . 2b ) , also resulted in a significant 202 decrease in intracellular iron levels , in this case in the mesenchymal - enriched OVCAR8 203 human high - grade serous ovarian cancer cell line ( Fig . 2e , 2f ) . Furthermore , we noted 204 that treatment of AGPS KO cells with ferric ammonium citrate ( FAC ) 36 , 37 , which provides 205 an exogenous source of ferric ions re - sensitized cultured AGPS KO mesenchymal 206 breast and ovarian carcinoma cells to ferroptosis induction , doing so even in the 207 absence of elevated ether phospholipids ( Fig . 2g , 2h ) . 208 We further extended this analysis by studying the behavior of mammary 209 carcinoma cells forming tumors in vivo . Consistent with our in vitro data , inductively 210 coupled plasma mass spectrometry indicated that total iron levels are reduced in breast 211 tumors derived from implanted pB3 AGPS KO carcinoma cells relative to those arising 212 from pB3 wildtype ( WT ) or control pB3 AGPS - addback cells ( Fig . 2i ) . Such observations 213 reinforced the notion that ether lipids are critical regulators of intracellular iron levels , a 214 rate - limiting component of ferroptosis . 215 216 Ether lipids facilitate CD44 - mediated iron endocytosis 217 We proceeded to investigate the mechanism ( s ) by which membrane - associated 218 ether lipids regulate intracellular iron content . This led us to examine the behavior of two 219 proteins that act as major mediators of cellular iron import - transferrin receptor 1 220 ( TfR1 ) 38 and CD44 32 â€“ and whether their functioning was altered in response to loss of 221 ether phospholipids . While CD44 is best known as a cell - surface cancer stem - cell 222 marker 39 , 40 , recent research revealed its critical role in mediating endocytosis of iron - 223 bound hyaluronates in CSC - enriched cancer cells and in activated immune cells 32 , 41 . To 224 monitor these two alternative iron import mechanisms , we performed endocytosis 225 kinetics experiments using fluorescently labeled transferrin as a proxy for TfR1 226 internalization and fluorescently labeled hyaluronic acid ( HA ) , whose main plasma 227 membrane receptor is CD44 , as a marker for CD44 internalization 42 , 43 . 228 Here we observed that the rate of endocytosis of TfR1 was marginally affected by 229 a deficiency of ether lipids in pB3 breast cancer cells ( Fig . 3a ) . In stark contrast , CD44 - 230 mediated endocytosis was significantly impaired when the AGPS gene was knocked out 231 in this ether lipid - deficient , cancer cells ( Fig . 3b ) . Conversely , CD44 - dependent iron 232 import could be restored to normal levels by introduction of a functional AGPS gene into 233 these AGPS KO cells ( Fig . 3b ) . Reduction in the rate of internalization of CD44 but not 234 TfR1 could also be observed in ether lipid - deficient PyMT - 1099 TGF - Î² - treated breast 235 cancer cells ( Fig . 3c , 3d ) . Hence , in these cells , ether lipids played a critical role in 236 modulating intracellular iron concentration by regulating endocytosis of CD44 but not 237 transferrin receptor . These findings were consistent with our previous observations that 238 TfR1 and CD44 localize to distinct endocytic vesicles in CSC - enriched cancer cells 32 , 44 239 making plausible that their internalization was governed by independent endocytic 240 mechanisms . 241 To further support the role of CD44 in promoting iron uptake â€“ acting via its 242 endocytosis of HA â€“ we demonstrate that knocking out the gene encoding CD44 or , 243 alternatively , treating cancer cells with hyaluronidase , led to a significant reduction in 244 intracellular iron levels ( Fig . 3e ) . Conversely , supplementing these cells with hyaluronic 245 acid increased intracellular iron levels ( Fig . 3e ) . Similar observations were seen in 246 human OVCAR8 cells ( Extended Data Fig . 3a ) . Taken together , these observations 247 further supported the influential role of CD44 in mediating iron uptake in these cancer 248 cells 32 . 249 We then studied whether the observed defect in CD44 endocytosis observed in 250 ether lipid deficient cells was limited to CD44 or , instead , reflected a general impairment 251 in the endocytosis of a variety of plasma membrane - associated glycoproteins . In fact , 252 CD44 is known to undergo a type of clathrin - and dynamin - independent form of 253 endocytosis 44 - 46 . This alternative mechanism of endocytosis differs from the one 254 regulating TfR1 recycling , which undergoes clathrin - mediated endocytosis , in which 255 small invaginations of clathrin - coated pits undergo scission facilitated by the GTPase 256 dynamin 45 , 47 . 257 To test whether loss of ether phospholipids had a wider effect on the clathrin - and 258 dynamin - independent mode of endocytosis , we examined the rate of uptake of dextran 259 ( 70 kDa ) , a branched polysaccharide known to undergo endocytosis by a clathrin - 260 independent mechanism 45 . Similar to CD44 , we observed that loss of AGPS also 261 exhibited a significant reduction in the rate of dextran endocytosis ; this behavior could 262 be reversed by restoration of ether phospholipids levels achieved by AGPS 263 complementation ( Fig . 3f , 3g ) . Moreover , the loss of ether lipids had a negligible effect 264 on the rate of EGFR endocytosis which , like TfR1 , is known to rely on clathrin - mediated 265 endocytosis ( Fig . 3h , Extended Data Fig . 3b ) . 266 Hence , these observations reinforced the notion that the internalization of 267 extracellular and cell - surface molecules is mediated by at least two distinct mechanisms 268 that differ in their dependence on ether phospholipids . More specifically , these findings 269 provided strong support for the involvement of a widely acting clathrin - and dynamin - 270 independent form of endocytosis , on which CD44 internalization depended 32 , 48 - 50 and is 271 significantly compromised in ether lipid - deficient cells . 272 273 Ether lipid deficiency impairs membrane biophysical properties 274 The above observations did not provide mechanistic insights into how changes in 275 the composition of membrane ether lipids could exert an effect on CD44 internalization . 276 As observed by others , non - clathrin - mediated endocytosis , which is employed by CD44 , 277 is particularly sensitive to changes in the physicochemical properties of the lipid bilayer 278 forming plasma membranes 46 , 51 - 56 . Such changes can influence membrane tension , 279 membrane fluidity and stability , and formation of lipid rafts , all of which , in turn , impact 280 the assembly and dynamics of clathrin - independent , cell - surface endocytic structures . 281 Hence , we hypothesized that ether lipids alter the biophysical properties of the lipid 282 bilayer of the plasma membrane to facilitate elevated iron endocytosis via CD44 . 283 Membrane deformability can be gauged by the parameter of membrane tension , 284 which measures the forces exerted on a defined cross - section of the plasma 285 membrane . It is influenced by both the in - plane tension of the lipid bilayer and the 286 attachment of the plasma membrane to the underlying cell cortex 57 , 58 . Indeed , 287 alterations in membrane tension have long been demonstrated to affect endocytosis 59 - 288 64 , prompting us to assess the effects of loss of ether lipids on plasma membrane 289 tension . To quantify membrane tension directly , we generated a membrane tether using 290 an optically trapped bead and measured the pulling force ( f ) and the tube radius ( R ) to 291 calculate membrane tension ( Ïƒ ) of living cells 48 , 65 ( Fig . 4a , 4b ) . We found that depletion 292 of ether phospholipids led to a significant increase in membrane tension in pB3 AGPS 293 KO cells relative to the corresponding pB3 WT cancer cells ( Fig . 4c ) . This shift was 294 largely attenuated upon restoration of AGPS expression in pB3 AGPS KO cells or upon 295 exposure of cultured cells to liposomes composed of polyunsaturated ether 296 phospholipids ( Fig . 4c ) . Treatment of pB3 AGPS KO cells with these ether lipid - 297 containing liposomes also increased the rate of CD44 endocytosis to levels comparable 298 to those of pB3 WT cells ( Fig . 4d ) . No changes were observed in the rate of clathrin - 299 dependent TfR1 endocytosis under these conditions ( Fig . 4e ) . Taken together , these 300 results provided the first indication that ether lipids facilitate CD44 - mediated iron 301 endocytosis in cancer cells , in part , by decreasing membrane tension . 302 Membrane lipid packing can also impact endocytosis 66 - 68 . It is related to the 303 fluidity or viscosity of the lipid bilayer , with higher lipid packing correlating with higher 304 viscosity . This , in turn , affects the ease with which proteins and lipids undergo lateral 305 diffusion and conformational changes within a lipid bilayer , thereby affecting 306 endocytosis - related signaling 48 . This motivated us to investigate the contribution of ether 307 lipids to membrane lipid packing . To do so , we used the C - laurdan lipid - based , polarity - 308 sensitive dye , which yields a spectral emission shift dependent on the degree of lipid 309 packing 69 . These measurements are used to calculate a unitless index , termed 310 generalized polarization ( GP ) , where a higher GP indicates increased lipid packing 69 . 311 Our measurements using the C - laurdan dye indicated that a reduction in ether lipid 312 levels resulted in a measurable , significant increase in membrane packing ( Fig . 4f - 4h ) , 313 which , like increase increases in membrane tension , negatively affects membrane 314 plasticity 66 . 315 A third parameter governing the biophysical properties of lipid bilayers involves 316 the stability ( size and lifetime ) of lipid rafts . This parameter can be gauged by monitoring 317 the miscibility transition temperature ( T misc ) of these membranes 70 . The association of 318 CD44 with lipid rafts , which are dynamically formed plasma membrane microdomains , is 319 known to be critical for CD44 - mediated HA endocytosis 71 . We reasoned that a decrease 320 in the stability of lipid rafts , and thus a decrease in T misc , would result in impairment of 321 CD44 endocytosis 70 . Thus , we measured the effect of loss of ether lipids on the 322 miscibility transition temperature . In fact , we observed a decrease in T misc upon loss of 323 AGPS in pB3 cancer cells , which indicated a decrease in lipid raft stability . This finding 324 supports a role for ether lipids in maintaining the plasma membrane organization 325 through lipid raft microdomains ( Fig . 4i ) , revealing yet another biophysical property of 326 lipid bilayers that can influence CD44 endocytosis . 327 It is noteworthy that clathrin - independent endocytosis exhibits a greater 328 dependency on the membrane biophysical properties assessed above 46 , 51 - 56 . This may 329 explain why loss of ether lipids can exert a significant effect on the rate of CD44 - 330 mediated iron endocytosis but negligible effects on the clathrin - mediated TfR1 331 endocytosis . Furthermore , these findings illuminated a mechanism by which membrane - 332 associated ether lipids could govern a major mechanism of iron internalization , which in 333 turn could impact the vulnerability of cancer cells to ferroptosis inducers . 334 335 Loss of ether lipids decreases metastasis and cancer cell stemness 336 Prior studies have demonstrated that reduced membrane tension and elevated 337 intracellular iron can promote cancer metastasis 72 - 76 . These findings of others caused us 338 to investigate whether changes in the ether lipid composition of cancer cells impacted 339 key steps of the multi - step invasion - metastasis cascade , notably extravasation 340 efficiency , post - extravasation proliferation 77 , as well as the functionally critical trait of 341 cancer cell stemness , i . e . , tumor - initiating ability . 342 We measured extravasation efficiency by employing an in vitro three - dimensional 343 microvascular network system composed of human umbilical vein endothelial cells 344 ( HUVECs ) and normal human lung fibroblasts . This system has been shown to 345 accurately model some of the complex biological processes associated with cancer cell 346 extravasation 78 - 82 . Using this defined experimental system , we found that loss of ether 347 lipids significantly decreased extravasation efficiency ( Fig . 5a - 5c ) . Furthermore , we 348 observed a strong reduction in overall metastatic burden following intracardiac injection 349 in syngeneic hosts of the pB3 AGPS KO breast cancer cells relative to corresponding 350 wildtype cells ( Fig . 5d - 5f ) . As an important control in these experiments , we determined 351 that ether lipid deficiency in these cells had a modest effect on primary tumor growth 352 kinetics , making it unlikely that the loss of ether phospholipids had a significant effect on 353 post - extravasation proliferation of disseminated tumor cells ( Fig . 5g - 5i ) . A decrease in 354 metastatic burden was also observed upon knockout of AGPS and FAR1 in OVCAR8 355 cancer cells , and upon loss of CD44 in pB3 cancer cells ( Extended Data Fig . 4a - 4c ) . 356 Given that high CD44 expression and elevated intracellular iron levels are 357 positively correlated with cancer cell stemness 32 , 39 , 83 , we investigated whether ether 358 lipid deficiency also affects the tumor - initiating capacity of cancer cells as gauged by an 359 experimental limiting dilution tumor - implantation assay . These experiments indicated 360 that loss of ether lipids in pB3 breast cancer cells decreases cancer cell stemness ( Fig . 361 5j , Extended Data Fig . 4d ) , which , as we have found in other investigations , serve as a 362 reliable marker of metastasis - initiating capacity 84 . In addition , we found that loss of ether 363 lipids significantly attenuates the tumor - initiating potential and metastatic capacity of 364 PyMT - 1099 AGPS KO TGF - Î² - treated ( ether lipid deficient ) cancer cells following 365 implantation into the orthotopic site â€“ â€“ the mammary stromal fat pad ( Fig . 5k - 5m ) . 366 Hence , ether lipids play critical roles in promoting cancer cell stemness and resulting 367 post - extravasation colonization . 368 369 DISCUSSION 370 The present findings indicate the need to consider the complex interplay between 371 genetics and the biophysical properties of cell membranes as determinants of cancer 372 cell fate and emphasize the potential role of lipids and metals in this process . 373 Membrane - associated phospholipids have previously been implicated as important 374 mediators of cell transformation , in large part through the actions of inositol 375 phospholipids and their derivatives 85 . In the present study , we shed light on an entirely 376 different and poorly studied role of lipids in influencing cell fate through their effects on 377 membrane biophysical properties and their impact on iron homeostasis . Specifically , we 378 uncover a mechanism whereby alterations in ether lipids affect the biophysical 379 properties of the plasma membrane to impact distinct cell - biological processes â€“ â€“ iron 380 uptake and neoplasia - related phenotypes , notably metastasis and cancer cell 381 stemness / tumor - initiating ability . Importantly , this biochemical configuration creates a 382 unique vulnerability of cancer cells to ferroptosis , and suggests that targeting lipid 383 metabolism and iron homeostasis could be exploited to suppress subpopulations of 384 highly metastatic and drug - tolerant carcinoma cells 86 . 385 Ether phospholipids have been widely portrayed as participants in ferroptosis 386 through their role as substrates prone to iron - catalyzed peroxidation . However , our 387 findings indicate an entirely different mechanism whereby ether lipids directly modulate 388 the levels of intracellular iron , a rate - limiting component governing ferroptosis 389 susceptibility 4 , 32 , 73 . By emphasizing the role of membrane biophysical properties in 390 governing iron uptake , we depart from the conventional focus limited to portraying 391 phospholipids as substrates for peroxidation . This shift in perspective has the potential 392 to open new avenues for research , as it challenges researchers to explore the 393 biophysical aspects of membranes as a new dimension in the regulation of this cell 394 death program . 395 Alterations in intracellular iron level can impact gene expression via various 396 mechanisms including modulation of chromatin - modifying enzyme activity 32 , 87 , 88 . For 397 example , increase of intracellular iron levels has been shown to promote the activity of 398 iron - dependent demethylases 32 , 87 , 88 , impacting gene expression profiles underlying cell 399 plasticity 32 and immune cell activation 41 . Our finding that ether lipid deficiency reduces 400 intracellular iron levels explains , at least in part , how loss of ether lipids may impact 401 cancer - associated transcriptional programs , acting at the epigenetic level and enabling 402 a variety of malignancy - associated cell phenotypes including metastasis and cancer 403 stemness . Such mechanisms may act in concert with non - iron - dependent processes , 404 which are also regulated by ether lipids to affect cancer malignancy traits . 405 The implications of our research findings may extend far beyond the realm of 406 cancer pathogenesis . We speculate that the biophysical modulation of membranes and 407 its intersection with iron biology could be a widely - acting determinant of cell fate , 408 impacting processes such as differentiation , immune activation , wound healing , and 409 embryonic development . 410 411 ACKNOWLEDGMENTS 412 We thank all members of the Weinberg , Farese and Walther labs for insightful 413 discussions and reagents . We are grateful to Brent Stockwell , Laurie Boyer and Fabien 414 Sindikubwabo for helpful discussions . We acknowledge technical support from Caroline 415 A . Lewis , Zon W . Lai and Marina Plays , the CurieCoreTech Metabolomics and 416 Lipidomics Technology Platform at the Institut Curie , the following facilities at the 417 Whitehead Institute : Metabolite Profiling Core , W . M . Keck Microscopy Core , Flow 418 Cytometry Core , as well as the Koch Institute ' s Robert A . Swanson ( 1969 ) 419 Biotechnology Center , specifically the MIT Koch Institute small animal imaging core and 420 MIT Tang Histology facility . 421 This work was funded in part by the National Institutes of Health : R37GM058615 422 ( VWH ) , the National Cancer Institute K99CA255844 / R00CA255844 ( NB ) , and the 423 National Cancer Institute ( RDK ) . Additional funding support was received from MIT 424 Stem Cell ( RAW ) , Brendan Bradley Gift ( RAW ) , Nile Albright Research Foundation 425 ( RAW ) , Samuel Waxman Cancer Research Foundation ( RAW ) , Virginia , D . K . Ludwig 426 Fund for Cancer Research Center ( RAW ) , European Research Council under the 427 European Unionâ€™s Horizon 2020 research and innovation programme grant agreement 428 No 647973 ( RR ) , Foundation Charles Defforey - Institut de France ( RR ) , Ligue Contre le 429 Cancer Equipe LabellisÃ©e ( RR ) , Fondation Bettencourt Schueller ( RR ) , Marble Center 430 for Cancer Nanomedicine ( PTH ) , Jane Coffin Childs Memorial Fund ( WSH ) , Ludwig 431 Center at MITâ€™s Koch Institute for Integrative Cancer Research ( WSH ) and the New 432 Horizon UROP Fund / MIT ( VVP ) . 433 434 AUTHOR CONTRIBUTIONS 435 W . S . H . and R . R . conceived the project . S . M . performed iron measurement studies and 436 oxidized lipidomics analysis . J . Y . performed endocytosis assays . Membrane tension 437 and membrane fluidity studies were performed by S . I . and K . R . L . , respectively . S . D . 438 and F . R . assisted with animal experiments . Z . W . performed extravasation assays . 439 J . L . S . , performed oxidized lipidomic analyses . Liposomal nanoparticles and HA - Cy3 440 probes were synthesized by N . B . and A . V . All other experiments and data analysis were 441 performed by W . S . H . with assistance from V . V . P . , K . S . , G . W . B . , and E . E . W . S . H . wrote 442 the manuscript . R . A . W . and R . R . edited the manuscript with input from all authors . 443 444 COMPETING INTERESTS 445 The authors declare no competing interests . 446 447 FIGURE LEGENDS 448 449 Fig . 1 . Ether lipids play a key role in maintaining a ferroptosis susceptible cell 450 state . See also Extended Data Fig . 1 . 451 a . Schematic of experimental model for lipidomic analysis . 452 b . Immunoblot analysis for AGPS expression in PyMT - 1099 WT or AGPS KO cells . 453 Cells were treated with TGF - Î² ( 2 ng / ml ) for 10 d where indicated . 454 c . Cell viability following treatment with the GPX4 inhibitor ML210 for 72 h . 1099 WT or 455 AGPS KO cells were pretreated with TGF - Î² ( 2 ng / ml ) for 10 d prior to assay . Graph 456 is representative of two independent biological replicates . 457 d . Bar graph showing percent of total lipids constituted by ether lipids following AGPS 458 KO in untreated wildtype ( WT ) or TGF - Î² - treated ( 2 ng / ml ; 10 d ) PyMT - 1099 cells . 459 e . Pie chart showing the relative proportion of ether lipids with various total numbers of 460 double bonds . 461 f . Amount in pmol of oxidized phosphatidylethanolamine ( Oxi . PE ) ether and ester 462 phospholipids in PyMT - 1099 TGF - Î² cells treated with ML210 for 24 h . Five biological 463 replicates per condition . 464 g . Volcano plot showing the log 2 fold change in the relative abundance of various lipid 465 species upon knockout of AGPS in PyMT - 1099 TGF - Î² - treated cells . Blue indicates 466 non - ether linked polyunsaturated phospholipids with a total of at least 3 double 467 bonds ; orange indicates all ether lipids identified in lipidomic analysis and black 468 denotes all other lipids identified . 469 h . Volcano plot showing the log 2 fold change in the relative abundance of various lipid 470 species upon knockout of AGPS in pB3 cells . Blue indicates non - ether linked 471 polyunsaturated phospholipids with a total of at least 3 double bonds ; orange 472 indicates all ether lipids identified in lipidomic analysis and black denotes all other 473 lipids identified . 474 i . Bar graph showing the percent of total lipids constituted by ether lipids in pB3 WT , 475 pB3 AGPS KO and pB3 AGPS addback cells . 476 j . Bar graph showing the effects of ether lipids on the relative abundance of selected 477 polyunsaturated diacyl phospholipids in pB3 cells . 478 Unless stated otherwise , all samples were analyzed in technical triplicates and shown 479 as the mean + / âˆ’ SEM . Statistical significance was calculated using unpaired , two - tailed 480 t - test . For figures 1h - 1j : pB3 WT and AGPS KO cells were transduced with the 481 respective vector control plasmids . pB3 AGPS addback cells are derivatives of AGPS 482 KO cells transduced with a murine AGPS expression vector . 483 484 Fig . 2 . Ether lipids regulate cellular redox - active iron levels in cancer cells . See 485 also Extended Data Fig . 2 . 486 a . Relative lysosomal iron levels based on Rhodox - M fluorescence intensity normalized 487 to the fluorescence intensity of lysotracker . Fold change is calculated relative to 488 untreated PyMT - 1099 wild - type ( WT ) cells . 489 b . Relative lysosomal iron levels based on Rhodox - M fluorescence intensity normalized 490 to the fluorescence intensity of lysotracker . Fold change is calculated relative to pB3 491 WT cells . 492 c . Inductively coupled plasma - mass spectrometry ( ICP - MS ) of cellular iron in PyMT - 493 1099 WT or AGPS KO cells pretreated with 2 ng / ml TGF - Î² for 10 d . 494 d . Inductively coupled plasma - mass spectrometry ( ICP - MS ) of cellular iron in pB3 cell 495 line derivatives . 496 e . Relative lysosomal iron levels in OVCAR8 NT sg , FAR1 KO or AGPS KO cells 497 pretreated with FAC ( 50 Âµg / ml ) for 24 h . Data shown are based on Rhodox - M 498 fluorescence intensity normalized to lysotracker fluorescence intensity . Fold change 499 is calculated relative to NT sg . 500 f . Inductively coupled plasma - mass spectrometry ( ICP - MS ) of cellular iron in OVCAR8 501 NT sg , FAR1 KO or AGPS KO cells pretreated with FAC ( 50 Âµg / ml ) for 24 h . 502 g . Cell viability of OVCAR8 NT sg , FAR1 KO or AGPS KO cells pretreated with FAC ( 50 503 Âµg / ml ) for 24 h followed by ML210 treatment for 72 h . 504 h . Cell viability in response to ML210 treatment . PyMT - 1099 WT or AGPS KO cells 505 were pretreated with TGF - Î² ( 2 ng / ml ) for 10 days followed by FAC treatment ( 100 506 Âµg / ml ) for an additional 24 h . Cells were then treated with ML210 in the presence or 507 absence of liproxstatin - 1 ( 0 . 2ÂµM ) and cell viability was assessed after 72 h . 508 i . ICP - MS of cellular iron from primary tumors derived from pB3 WT , pB3 AGPS KO , 509 and pB3 AGPS addback cells . Mean + / - SEM from 3 independent tumor samples per 510 condition . Each datapoint represents the average iron measurement from 5 technical 511 replicates per tumor sample . 512 All samples were analyzed with 3 - 6 technical replicates and shown as the mean + / âˆ’ 513 SEM unless stated otherwise . Statistical significance was calculated using unpaired , 514 two - tailed t - test . Abbreviation : NT â€“ nontargeting . 515 516 Fig . 3 . Ether lipids facilitate CD44 - mediated iron endocytosis . See also Extended 517 Data Fig . 3 . 518 a . Endocytic transport of fluorescently labeled transferrin as assessed by quantitative 519 colocalization with an early endosomal marker ( EEA1 ) in pB3 cells . 520 b . Endocytic transport of fluorescently labeled hyaluronate probe as assessed by 521 quantitative colocalization with an early endosomal marker ( EEA1 ) in pB3 cells . 522 c . Endocytic transport of fluorescently labeled transferrin as assessed by quantitative 523 colocalization with an early endosomal marker ( EEA1 ) in PyMT - 1099 WT or AGPS 524 KO cells pretreated with 2 ng / ml TGF - Î² for 10 d . 525 d . Endocytic transport of fluorescently labeled hyaluronate probe as assessed by 526 quantitative colocalization with an early endosomal marker ( EEA1 ) in PyMT - 1099 527 WT or AGPS KO cells pretreated with 2 ng / ml TGF - Î² for 10 d . 528 e . ICP - MS of cellular iron following treatment with either hyaluronan or hyaluronidase in 529 PyMT - 1099 WT or CD44 KO cells pretreated with 2 ng / ml TGF - Î² for 10 d . 530 f . Endocytic transport of dextran as assessed by quantitative colocalization with the 531 early endosomal marker EEA1 in pB3 cells . 532 g . Endocytic transport of dextran as assessed by quantitative colocalization with the 533 early endosomal marker EEA1 in PyMT - 1099 WT or AGPS KO cells pretreated with 534 2 ng / ml TGF - Î² for 10 d . 535 h . Endocytosis of EGFR as assessed by quantitative colocalization of internalized EGF 536 with an early endosomal marker ( EEA1 ) in PyMT - 1099 WT or AGPS KO cells 537 pretreated with 2 ng / ml TGF - Î² for 10 days . Cells were treated with 2 ng / ml EGF . 538 All data shown as mean + / âˆ’ SEM and statistical significance was calculated using 539 unpaired , two - tailed t - test ; Examined n = 10 fields of cells per experimental sample for all 540 endocytosis - related experiments and n = 4 replicates for ICP - MS . 541 542 Fig . 4 . Ether lipid deficiency impairs membrane biophysical properties . 543 a . Schematic of membrane tether pulling assay and fluorescence image showing a 544 tether pulled from the plasma membrane of a pB3 cell using an optically trapped 4 545 Âµm anti - Digoxigenin coated polystyrene bead . 546 b . Graph showing tether radius ( R ) and tether force measurements ( ð‘“ ) in pB3 WT , 547 AGPS KO , and AGPS addback cells . All data shown as mean + / âˆ’ SD . 548 c . Membrane tension measurements in pB3 WT , AGPS KO pretreated with 20ÂµM of the 549 indicated ether phospholipid liposomes , and AGPS addback cells . All data shown as 550 mean + / âˆ’ SEM . 551 d . Endocytic transport of fluorescently labeled hyaluronate probe as assessed by 552 quantitative colocalization with an early endosomal marker ( EEA1 ) in pB3 WT or 553 AGPS KO cells pretreated with 20ÂµM of the indicated ether phospholipid liposomes . 554 All data shown as mean + / âˆ’ SEM . 555 e . Endocytic transport of fluorescently labeled transferrin as assessed by quantitative 556 colocalization with an early endosomal marker ( EEA1 ) in pB3 WT or AGPS KO cells 557 pretreated with 20ÂµM of the indicated ether phospholipid liposomes . All data shown 558 as mean + / âˆ’ SEM . 559 f . GP values of C - Laurdan - labeled plasma membranes from pB3 WT , AGPS KO and 560 AGPS addback cells . Data is shown as mean GP + / âˆ’ SD . 561 g . GP values of C - Laurdan - labeled intracellular membranes from pB3 WT , AGPS KO 562 and AGPS addback cells . Data is shown as mean GP + / âˆ’ SD . 563 h . GP maps of C - Laurdan - labeled intracellular membranes from PyMT - 1099 WT or 564 AGPS KO cells treated with 2 ng / ml TGF - Î² for 10 d . Data shown as mean GP + / âˆ’ 565 SD . 566 i . Representative curves showing a leftward shift of the phase separation curve in 567 GPMVs from pB3 AGPS KO cells in comparison to wildtype pB3 control cells . This is 568 indicative of less stable phase separation upon loss of AGPS . Curves were 569 generated by counting > / = 20 vesicles / temperature / condition at > 4 temperature . The 570 data was fit to a sigmoidal curve to determine the temperature at which 50 % of the 571 vesicles were phase - separated ( T misc ) . Data shown as the average fits of 3 572 independent experiments . Inset showing a decrease in miscibility transition 573 temperatures ( T misc ) upon loss of AGPS in pB3 cells . Graph shows the mean + / - 574 SEM of 3 independent experiments . 575 Statistical significance was calculated using unpaired , two - tailed t - test . 576 577 Fig . 5 . Loss of ether lipids decreases metastasis and cancer cell stemness . See 578 also Extended Data Fig . S4 . 579 a . Representative confocal images of extravasated tdTomato - labeled pB3 WT and 580 AGPS KO cells from an in vitro microvascular network established using HUVEC 581 ( green ) and normal human lung fibroblasts ( unlabeled ) , over a time period of 24 h . 582 b . Quantification of extravasated tdTomato - labeled pB3 WT and AGPS KO cells from 583 an in vitro microvascular network established using HUVEC ( green ) and normal 584 human lung fibroblasts ( unlabeled ) , over a time period of 24 h . Each datapoint 585 represents number of extravasated cells per device . Data is representative of two 586 independent biological replicates . Graph shows the mean + / - SEM and statistical 587 significance was calculated using unpaired , two - tailed t - test . 588 c . Quantification of extravasated tdTomato - labeled PyMT - 1099 cell line derivatives 589 from an in vitro microvascular network established using HUVEC ( green ) and normal 590 human lung fibroblasts ( unlabeled ) , over a time period of 24 h . Each datapoint 591 represents number of extravasated cells per device . Data is representative of two 592 independent biological replicates . Graph shows the mean + / - SEM and statistical 593 significance was calculated using unpaired , two - tailed t - test . 594 d . Representative IVIS images of overall metastatic burden in C57BL / 6 female mice 595 following intracardiac injection of GFP - luciferized pB3 WT ( n = 5 ) and AGPS KO ( n = 5 ) 596 cells . Mean + / - SEM . 597 e . Quantification of overall metastatic burden in C57BL / 6 female mice following 598 intracardiac injection of GFP - luciferized pB3 WT ( n = 5 ) and AGPS KO ( n = 5 ) cells . 599 Mean + / - SEM . 600 f . Representative images of H & E - stained sections of harvested kidneys from C57BL / 6 601 female mice following intracardiac injection of pB3 WT or pB3 AGPS KO cells . 602 g . Gross images of primary tumors derived from pB3 WT control cells and pB3 AGPS 603 KO cells . 604 h . Tumor growth kinetics of primary tumors derived from pB3 WT control cells and pB3 605 AGPS KO cells . ( n = 5 mice per group ) . 606 i . Bar graph showing the average weight from primary tumors derived from pB3 WT 607 control cells and pB3 AGPS KO cells . Data shows the mean + / - SEM . 608 j . Estimated number of cancer stem cells ( CSCs ) per 10 , 000 cells as calculated by 609 extreme limiting dilution analysis ( ELDA ) software . Tumor - initiating capacity was 610 assessed following implantation of indicated amounts of pB3 WT or pB3 AGPS KO 611 cells into the mammary fat pad of C57BL / 6 mice . P values , Ï‡2 pairwise test . 612 k . Table showing the number of mice with palpable primary tumors at 121 d post 613 orthotopic implantation of PyMT - 1099 WT or AGPS KO cells pretreated with 2 ng / ml 614 TGF - Î² for 10 d into NSG female mice . 615 l . Quantification of lung metastases for aforementioned experiment . Data shows the 616 mean number of lung metastases + / - SEM . 617 m . Representative images of H & E - stained lungs harvested from C57BL / 6 female mice 618 following orthotopic injection of PyMT - 1099 WT or AGPS KO cells pretreated with 2 619 ng / ml TGF - Î² for 10 d . Lungs were harvested after 121 d post - injection . 620 621 EXTENDED DATA FIGURE LEGENDS 622 623 Extended Data Fig . 1 624 a . Schematic of peroxisomal - ether lipid biosynthetic pathway . 625 b . Cell viability following treatment with the GPX4 inhibitor RSL3 for 72 h . PyMT - 1099 626 WT or AGPS KO cells were pretreated with TGF - Î² ( 2 ng / ml ) for 10 d prior to assay . 627 Graph is representative of two independent biological replicates . 628 c . Amount in pmol of oxidized phosphatidylethanolamine ( Oxi . PE ) ether and ester 629 phospholipids in pB3 cells treated with RSL3 for 24 hours . Five biological replicates 630 per condition . 631 d . Immunoblot analysis for AGPS expression in mesenchymal - enriched pB3 WT , AGPS 632 KO , and AGPS addback cells . pB2 cells served as a control for expression of 633 epithelial - like markers . 634 635 Extended Data Fig . 2 636 a . Inductively coupled plasma - mass spectrometry ( ICP - MS ) of cellular iron in the 637 mesenchymal - enriched 687g WT and AGPS KO murine breast cancer cell line . 638 b . Immunoblot analysis of OVCAR8 AGPS KO , FAR1 KO or nontargeting sg ( control ) 639 cells . 640 Unless stated otherwise , all samples were analyzed in technical triplicates and shown 641 as the mean + / âˆ’ SEM . Statistical significance was calculated using unpaired , two - tailed 642 t - test . 643 644 Extended Data Fig . 3 645 a . ICP - MS of cellular iron following treatment with either hyaluronan or hyaluronidase in 646 OVCAR8 WT or CD44 KO cells . 647 b . Endocytosis of EGFR as assessed by quantitative colocalization of internalized EGF 648 with an early endosomal marker ( EEA1 ) in PyMT - 1099 WT or AGPS KO cells 649 pretreated with 2 ng / ml TGF - Î² for 10 days . Cells were treated with 200 ng / ml EGF . 650 All data shown as mean + / âˆ’ SEM and statistical significance was calculated using 651 unpaired , two - tailed t - test ; Examined n = 10 fields of cells per experimental sample for all 652 endocytosis - related experiments and n = 4 replicates for ICP - MS . 653 654 Extended Data Fig . 4 655 a . Bright - field ( top ) and fluorescence images ( bottom ) showing reduced mesenteric 656 metastases from athymic nude mice injected with tdTomato - labeled OVCAR8 NT sg , 657 AGPS KO and FAR1 KO cells via the intraperitoneal route . 658 b . Representative IVIS images of overall metastatic burden in C57BL / 6 female mice 659 following intracardiac injection of GFP - luciferized pB3 WT ( n = 5 ) and CD44 KO ( n = 6 ) 660 cells . Mean + / - SEM . 661 c . Quantification of overall metastatic burden in C57BL / 6 female mice following 662 intracardiac injection of GFP - luciferized pB3 WT ( n = 5 ) and CD44 KO ( n = 6 ) cells . 663 Mean + / - SEM . 664 d . Table showing number of cells implanted per mice for limiting dilution assay . 665 666 METHODS 667 Cell lines 668 The pB3 MMTV - PyMT - derived murine breast cancer cell line was a kind gift from the 669 laboratory of Harold L . Moses 29 . 687g cells ( also called EpCAM Lo Snail - YFP Hi ) were 670 originally established from tumors that developed in the MMTV - PyMT - Snail - IRES - YFP 671 reporter mouse model , previously developed by the Weinberg lab 89 . pB3 and 687g cell 672 lines were cultured in 1 : 1 DMEM / F12 medium containing 5 % adult bovine serum with 673 1 % penicillin - streptomycin and 1 % non - essential amino acids 29 . The PyMT - 1099 murine 674 breast cancer cell line was a kind gift from the laboratory of Gerald Christofori and 675 cultured in DMEM supplemented with 10 % fetal bovine serum , 1 % penicillin - 676 streptomycin and 1 % glutamine 26 . These cells were treated with 2 ng / ml of TGF - Î² for 10 677 days , prior to performing any subsequent analyses . OVCAR8 cells were obtained from 678 the laboratory of Joan Brugge and cultured in 1 : 1 MCDB 105 medium / Medium 199 679 Earleâ€™s Eagles medium supplemented with 10 % fetal bovine serum and 1 % penicillin - 680 streptomycin . All cells were cultured in a humidified incubator at 37Â°C with 5 % CO 2 . All 681 cells were negative for mycoplasma . Human cell line authentication ( CLA ) analysis of 682 OVCAR8 cells were performed by the Duke University DNA Analysis facility . 683 Established murine lines have not been STR profiled . 684 685 Animal studies 686 All animal studies were conducted according to the MIT Committee on Animal Care 687 protocol . For primary tumor growth studies : 1 million cells were resuspended in 20 % 688 Matrigel / PBS and injected into the mammary fat pad of 6 - 8 weeks old female mice . 689 C57BL / 6 mice ( Jackson Laboratories ) were used for in vivo experiments with pB3 cells . 690 NSG mice were used for in vivo experiments with PyMT - 1099 cells . These cells were 691 pretreated with TGF - Î² ( 2 ng / ml ) for 10 days prior to injection . Tumor size was measured 692 once a week using a vernier caliper and tumor volume was calculated using the 693 formula : Tumor volume = length x width 2 / 2 , where length represents the largest tumor 694 diameter and width represents the perpendicular tumor diameter . For limiting dilution 695 tumor - initiating assays : pB3 WT or pB3 AGPS KO cells were resuspended in 20 % 696 Matrigel / PBS and injected into the mammary fat pad of 6 - 8 weeks old female C57BL / 6 697 mice ( Jackson Laboratories ) at the following dilutions : 100 , 000 , 10 , 000 , 1000 , 100 cells . 698 Animals were assessed for palpable tumors after 39 days post injection . The estimated 699 number of CSCs was calculated using the extreme limiting dilution analysis ( ELDA ) 700 software . For experimental metastasis involving pB3 cell lines , 0 . 2 million cells were 701 resuspended in 200Âµl of PBS and injected into the left ventricle of 6 - 8 weeks old female 702 C57BL / 6 mice . Metastatic burden was measured after 10 d post - injection via 703 bioluminescence in live animals using the IVIS Spectrum in vivo imaging system . 704 Images were analyzed using Living Image software ( PerkinElmer ) . For OVCAR8 cells , 705 1 . 5 million cells were resuspended in PBS and implanted into 6 - 8 weeks old female 706 athymic nude mice ( Jackson Laboratories ) via intraperitoneal injections . Metastatic 707 burden was assessed after 6 weeks using a fluorescence dissecting microscope . 708 709 Generation of gene - edited cell lines using CRISPR / Cas9 710 With the exception of OVCAR8 cells , all AGPS KO single cell clones were generated via 711 transient transfection with mouse AGPS CRISPR / Cas9 KO Plasmids ( Catalog no . sc - 712 432759 , Santa Cruz ) according to the manufacturerâ€™s instructions . GFP - positive cells 713 were sorted via fluorescence - activated cell sorting ( FACS ) into 96 - well plates with one 714 cell per well and single cell clones were subsequently expanded . AGPS KO single cell 715 clones were assessed for loss of AGPS expression via western blot analysis . pB3 716 AGPS addback cells were generated by transducing AGPS KO single cell clone with 717 pLV [ Exp ] - Puro - EF1A - mAgps lentiviral vector ( VectorBuilder ) . pB3 AGPS KO cells 718 expressing pLV [ Exp ] - Puro - EF1A - Stuffer _ 300bp ( VectorBuilder ) were established as 719 controls and noted as pB3 AGPS KO + EV in the manuscript . Lentivirus was produced 720 by transfecting HEK293T cells with viral envelope ( VSVG , Addgene ) and packaging 721 plasmids ( psPAX2 , Addgene ) . Viral supernatant was collected after 48 h and filtered 722 through a 0 . 45Âµm filter . Stably transduced cells were selected with 2 Âµg / ml puromycin . 723 OVCAR8 FAR1 KO and AGPS KO single cell clones as well as nontargeting control 724 cells , were established as previously described 19 . pB3 CD44 KO cells ( bulk ) were 725 generated using human CD44 CRISPR / Cas9 KO Plasmids ( Catalog no . sc - 419558 , 726 Santa Cruz ) according to the manufacturerâ€™s instructions . After 48 h post - transfection , 727 cells were sorted by flow cytometry for GFP positive cells , expanded in culture , and re - 728 sorted twice for CD44 negative cells using Alexa FluorÂ® 647 anti - mouse / human CD44 729 Antibody . Cells were maintained as bulk CD44 KO cells . 730 731 732 Plasmids Source pLV [ Exp ] - Puro - EF1A - Agps ( mouse ) VectorBuilder pLV [ Exp ] - Puro - EF1A - Stuffer _ 300bp VectorBuilder Mouse AGPS CRISPR / Cas9 KO Plasmids Catalog no . sc - 432759 , Santa Cruz Mouse CD44 / HCAM CRISPR / Cas9 KO Plasmids Catalog no . sc - 419558 , Santa Cruz LentiCRISPRv2 - puro - Nontargeting Published 19 LentiCRISPRv2 - puro - human AGPS sg Published 19 LentiCRISPRv2 - puro - human FAR1 sg Published 19 pLV - EF1A - eGFP - LUC VectorBuilder pCDH - EF1 - Luc2 - P2A - tdTomato Plasmid # 72486 , Addgene 733 Lipidomics analysis 734 735 Lipid extraction for mass spectrometry lipidomics 736 Mass spectrometry - based lipid analysis was performed by Lipotype GmbH ( Dresden , 737 Germany ) as described 90 . Lipids were extracted using a chloroform / methanol 738 procedure 91 . Samples were spiked with internal lipid standard mixture containing : 739 cardiolipin 14 : 0 / 14 : 0 / 14 : 0 / 14 : 0 ( CL ) , ceramide 18 : 1 ; 2 / 17 : 0 ( Cer ) , diacylglycerol 740 17 : 0 / 17 : 0 ( DAG ) , hexosylceramide 18 : 1 ; 2 / 12 : 0 ( HexCer ) , lyso - phosphatidate 17 : 0 741 ( LPA ) , lyso - phosphatidylcholine 12 : 0 ( LPC ) , lyso - phosphatidylethanolamine 17 : 1 ( LPE ) , 742 lyso - phosphatidylglycerol 17 : 1 ( LPG ) , lyso - phosphatidylinositol 17 : 1 ( LPI ) , lyso - 743 phosphatidylserine 17 : 1 ( LPS ) , phosphatidate 17 : 0 / 17 : 0 ( PA ) , phosphatidylcholine 744 17 : 0 / 17 : 0 ( PC ) , phosphatidylethanolamine 17 : 0 / 17 : 0 ( PE ) , phosphatidylglycerol 745 17 : 0 / 17 : 0 ( PG ) , phosphatidylinositol 16 : 0 / 16 : 0 ( PI ) , phosphatidylserine 17 : 0 / 17 : 0 ( PS ) , 746 cholesterol ester 20 : 0 ( CE ) , sphingomyelin 18 : 1 ; 2 / 12 : 0 ; 0 ( SM ) , triacylglycerol 747 17 : 0 / 17 : 0 / 17 : 0 ( TAG ) . After extraction , the organic phase was transferred to an infusion 748 plate and dried in a speed vacuum concentrator . The dry extract was re - suspended in 749 7 . 5 mM ammonium formiate in chloroform / methanol / propanol ( 1 : 2 : 4 , V : V : V ) . All liquid 750 handling steps were performed using Hamilton Robotics STARlet robotic platform with 751 the Anti Droplet Control feature for organic solvents pipetting . 752 753 MS data acquisition 754 Samples were analyzed by direct infusion on a QExactive mass spectrometer ( Thermo 755 Scientific ) equipped with a TriVersa NanoMate ion source ( Advion Biosciences ) . 756 Samples were analyzed in both positive and negative ion modes with a resolution of 757 R m / z = 200 = 280000 for MS and R m / z = 200 = 17500 for MSMS experiments , in a single 758 acquisition . MSMS was triggered by an inclusion list encompassing corresponding MS 759 mass ranges scanned in 1 Da increments 92 . Both MS and MSMS data were combined 760 to monitor CE , DAG and TAG ions as ammonium adducts ; LPC , LPC O - , PC , PC O - , as 761 formiate adducts ; and CL , LPS , PA , PE , PE O - , PG , PI and PS as deprotonated anions . 762 MS only was used to monitor LPA , LPE , LPE O - , LPG and LPI as deprotonated anions ; 763 Cer , HexCer and SM as formiate adducts . 764 765 Data analysis and post - processing 766 Data were analyzed with in - house developed lipid identification software based on 767 LipidXplorer 93 , 94 . Only lipid identifications with a signal - to - noise ratio > 5 , and a signal 768 intensity 5 - fold higher than in corresponding blank samples were considered for further 769 data analysis . Simple imputation of missing values was performed by replacing missing 770 values with 0 . 5 * minimum non - zero value for each lipid assayed . Relative level of total 771 ether lipids was determined by summing the pmol value of all ether lipids identified 772 followed by normalization to total lipids . 773 774 Oxidized lipidomics 775 100 , 000 cells per condition were plated in 6 - well plates 24 h prior to the experiment . For 776 1099 , cells were treated with TGF - Î² for 10 d . pB3 cells were treated with 500 nM RSL3 , 777 OVCAR8 cells with 2 ÂµM ML210 and TGF - Î² - treated 1099 cells with 10 ÂµM ML210 for 24 778 h . Cells were subsequently washed with 1x PBS and then with 150 mM ammonium 779 bicarbonate . Cells were then scraped and resuspended in 150 mM ammonium 780 bicarbonate and centrifuged at 300 g for 5 min . The supernatant was removed and cells 781 were resuspended in 1 mL of 150 mM ammonium bicarbonate . The solutions were 782 centrifuged at 12 , 000 RPM for 10 min and the supernatant was removed . 200 ÂµL of 150 783 mM sodium bicarbonate was added to the pellet and samples were flash frozen in liquid 784 nitrogen . Cells were prepared in 5 independent biological replicates and lipidomics 785 analysis was performed on the same day for all the replicates . For lipidomics analysis , 786 the 200 ÂµL cell lysates were spiked with 1 . 4 Î¼L of internal standard lipid mixture 787 containing 300 pmol of phosphatidylcholine 17 : 0 - 17 : 0 , 50 pmol of 788 phosphatidylethanolamine 17 : 0 - 17 : 0 , 30 pmol of phosphatidylinositol 16 : 0 - 16 : 0 , 50 pmol 789 of phosphatidylserine 17 : 0 - 17 : 0 , 30 pmol of phosphatidylglycerol 17 : 0 - 17 : 0 and 30 pmol 790 of phosphatidic acid 17 : 0 - 17 : 0 and subjected to lipid extraction at 4 Â°C , as previously 791 described 95 . The sample was then extracted with 1 mL of chloroform - methanol ( 10 : 1 ) for 792 2 h . The lower organic phase was collected , and the aqueous phase was re - extracted 793 with 1 mL of chloroform - methanol ( 2 : 1 ) for 1 h . The lower organic phase was collected 794 and evaporated in a SpeedVac vacuum concentrator . Lipid extracts were dissolved in 795 100 Î¼L of infusion mixture consisting of 7 . 5 mM ammonium acetate dissolved in 796 propanol : chloroform : methanol [ 4 : 1 : 2 ( vol / vol ) ] . Samples were analyzed by direct 797 infusion in a QExactive mass spectrometer ( Thermo Fisher Scientific ) equipped with a 798 TriVersa NanoMate ion source ( Advion Biosciences ) . 5 ÂµL of sample were infused with 799 gas pressure and voltage set to 1 . 25 psi and 0 . 95 kV , respectively . PC , PE , PEO , PCOx 800 and PEOx were detected in the 10 : 1 extract , by positive ion mode FTMS as protonated 801 aducts by scanning m / z = 580 â€“ 1000 Da , at R m / z = 200 = 280 000 with lock mass activated at 802 a common background ( m / z = 680 . 48022 ) for 30 s . Every scan is the average of 2 micro - 803 scans , automatic gain control ( AGC ) was set to 1E6 and maximum ion injection time 804 ( IT ) was set to 50 ms . PG and PGOx were detected as deprotonated adducts in the 805 10 : 1 extract , by negative ion mode FTMS by scanning m / z = 420 â€“ 1050 Da , at 806 R m / z = 200 = 280 000 with lock mass activated at a common background ( m / z = 529 . 46262 ) 807 for 30 s . Every scan is the average of 2 micro - scans . Automatic gain control ( AGC ) was 808 set to 1E6 and maximum ion injection time ( IT ) was set to 50ms . PA , PAOx , PI , PIOx , 809 PS and PSOx were detected in the 2 : 1 extract , by negative ion mode FTMS as 810 deprotonated ions by scanning m / z = 400 â€“ 1100 Da , at R m / z = 200 = 280 000 with lock mass 811 activated at a common background ( m / z = 529 . 46262 ) for 30 s . Every scan is the 812 average of 2 micro - scans , automatic gain control ( AGC ) was set to 1E6 and maximum 813 ion IT was set to 50 ms . All data was acquired in centroid mode . All lipidomics data 814 were analyzed with the lipid identification software , LipidXplorer 93 . Tolerance for MS and 815 identification was set to 2 ppm . Data were normalized to internal standards . 816 817 Immunoblotting 818 Cells were washed with ice - cold PBS and lysed in 1X Cell lysis buffer ( Cell Signaling 819 Technology , Cat . # 9803S ) containing 1mM PMSF protease inhibitor ( Cell Signaling 820 Technology , Cat . # 8553S ) . Protein samples were prepared with NuPAGE LDS Sample 821 Buffer ( Thermo Fischer Scientific , Cat . # NP0007 ) , NuPage Sample Reducing Agent 822 ( Thermo Fischer Scientific , Cat . # NP0004 ) , and heated at 70 ÂºC for 10 minutes . 823 Samples were resolved by SDS - PAGE , transferred to nitrocellulose ( Bio - Rad ) and 824 blocked in 5 % milk / TBST for 1 h at room temperature . Membranes were incubated 825 overnight with the respective primary antibodies at 4 ÂºC , washed with 1X TBST , 826 incubated with HRP - conjugated secondary antibodies and developed using 827 SuperSignal TM West Dura Extended Duration Substrate ( Thermo Fischer Scientific , Cat . 828 # 34076 ) . 829 830 Antibody information 831 The table below indicates the antibodies used for western blotting and flow cytometry 832 analyses . 833 Antibody Source Catalog No . E - Cadherin Cell Signaling Technology 3195S Zeb1 Cell Signaling Technology 3396S N - cadherin Cell Signaling Technology 13116S AGPS Invitrogen PA5 - 56400 FAR1 Novus Bio . NBP1 - 89847 Snail Cell Signaling Technology 3879S GAPDH Cell Signaling Technology 2118S CD44 ( Western Blot ) Abcam ab189524 Alexa FluorÂ® 647 anti - mouse / human CD44 Antibody BioLegend 103017 Anti - rabbit IgG , HRP - linked antibody Cell Signaling Technology 7074S Anti - mouse IgG , HRP - linked antibody Cell Signaling Technology 7076S 834 Cell viability assay 835 Cells were seeded in 96 - well black clear bottom plates ( Corning ) at 2000 or 3000 cells 836 ( 1099 + / - TGF - Î² ) and 6000 cells ( OVCAR8 ) per well . Approximately , 12 - 16 h post - 837 seeding , cells were treated with various drug concentrations using an HP D300e Digital 838 Dispenser unless stated otherwise . Cell viability was assessed at 72 h post - treatment 839 by performing CellTiter - Glo Luminescent Cell Viability Assays ( Promega ) according to 840 the manufacturerâ€™s instructions . Relative viability was calculated by normalizing to 841 untreated controls unless stated otherwise . Non - linear regression models were applied 842 to generate the regression fit curves using GraphPad Prism . Drug compounds were 843 purchased as indicated : RSL3 ( Selleck Chem ) , ML210 ( Sigma Aldrich ) , and 844 Liproxstatin - 1 ( Fisher Scientific ) . For experiments involving ferric ammonium citrate 845 ( FAC ) , FAC ( Sigma ) was prepared fresh in sterile 1Ã— PBS and manually added directly 846 to cell culture media at the indicated concentrations at the time of seeding into 96 - well 847 plates . Unless stated otherwise , cells were pretreated with FAC for 24 h prior to ML210 848 treatment . 849 850 Inductively coupled plasma mass spectrometry ( ICP - MS ) 851 Cells were treated for 24 h with Hyaluronic acid ( Carbosynth , FH45321 , 600 - 1000 kDa , 852 1 mg / mL ) or Hyaluronidase ( HD , Sigma - Aldrich , H3884 , 0 . 1 mg / mL ) as indicated . Glass 853 vials equipped with Teflon septa were cleaned with nitric acid 65 % ( VWR , Suprapur , 854 1 . 00441 . 0250 ) , washed with ultrapure water ( Sigma - Aldrich , 1012620500 ) and dried . 855 Cells were harvested and washed twice with 1Ã— PBS . Cells were then counted using an 856 automated cell counter ( Entek ) and transferred in 200ÂµL 1Ã— PBS to the cleaned glass 857 vials . The same volume of 1Ã— PBS was transferred into separate vials for the 858 background subtraction , at least in duplicate per experiment . For tumor samples , small 859 pieces of the tumors were added into pre - weighed cleaned glass vials . Samples were 860 lyophilized using a freeze dryer ( CHRIST , 22080 ) . Glass vials with lyophilized tumor 861 samples were weighed to determine the dry weight for normalization . Samples were 862 subsequently mixed with nitric acid 65 % and heated at 80Â°C overnight . Samples were 863 diluted with ultrapure water to a final concentration of 0 . 475 N nitric acid and transferred 864 to metal - free centrifuge vials ( VWR , 89049 - 172 ) for subsequent ICP - MS analyses . 865 Amounts of metals were measured using an Agilent 7900 ICP - QMS in low - resolution 866 mode , taking natural isotope distribution into account . Sample introduction was 867 achieved with a micro - nebulizer ( MicroMist , 0 . 2 mL / min ) through a Scott spray chamber . 868 Isotopes were measured using a collision - reaction interface with helium gas ( 5 mL / min ) 869 to remove polyatomic interferences . Scandium and indium internal standards were 870 injected after inline mixing with the samples to control the absence of signal drift and 871 matrix effects . A mix of certified standards was measured at concentrations spanning 872 those of the samples to convert count measurements to concentrations in the solution . 873 Values were normalized against cell number or dry weight . 874 875 Iron measurements using Rhodox - M 876 The lysosome - specific fluorescent Fe ( II ) probe RhoNox - M was synthesized in 3 steps 877 according to a previously published procedure 33 . 1 H NMR ( 300 MHz , CDCl 3 ) Î´ 7 . 93 878 ( 1H , d , J = 2 . 0 Hz ) , 7 . 45 ( 1H , dd , J = 8 . 5 Hz , 2 . 0 Hz ) , 7 . 40 â€“ 7 . 30 ( 3H , m ) , 7 . 05 ( 1H , d , J 879 = 8 . 5 Hz ) , 6 . 90 ( 1H , d , J = 7 . 0 Hz ) , 6 . 80 ( 1H , d , J = 8 . 0 Hz ) , 6 . 50 â€“ 6 . 44 ( 2H , m ) , 5 . 28 â€“ 880 5 . 35 ( 2H , m ) , 3 . 62 ( 6H , m ) , 2 . 97 ( 6H , s ) . MS ( ESI ) m / z : calcd . for C 24 H 25 N 2 O 3 [ M + H ] + 881 389 . 19 , found : 389 . 35 . Cells were incubated with 1 ÂµM Rhonox - M for 1 h or lysotracker 882 deep red ( Thermo Fisher Scientific L12492 ) according to the manufacturerâ€™s instructions 883 for 1 h . Cells were then washed twice with ice - cold 1Ã— PBS and suspended in 884 incubation buffer prior to being analysed by flow cytometry . For each condition , at least 885 10000 cells were counted . Data were recorded on a BD Accuri C6 ( BD Biosciences ) 886 and processed using Cell Quest ( BD Biosciences ) and FlowJo ( FLOWJO , LLC ) . The 887 signal for Rhonox - M was normalized against the signal of lysotracker of cells treated in 888 parallel . 889 890 Endocytosis experiments 891 Antibody against EEA1 was purchased from BD Biosciences ( Catalog no . 610456 ) . 892 Conjugated transferrin ( mouse ) - Alexa546 , dextran - Alexa555 , and EGF - Alexa555 were 893 purchased from Invitrogen . Cy3 - conjugated hyaluronan was synthesized in - house . Cy2 - 894 or Cy3 - conjugated donkey antibodies against mouse IgG were purchased from Jackson 895 ImmunoResearch . For receptor - mediated endocytosis , cells were washed with serum - 896 free medium and then incubated in this medium with Cy3 - conjugated hyaluronan ( 0 . 1 897 mg / ml ) , Alexa 555 - conjugated EGF ( either 2 ng / ml or 200 ng / ml ) , or Alexa 546 - 898 conjugated transferrin ( 5 Î¼g / ml ) for 1 hr at 4Â° C . Cells were then washed to clear 899 unbound ligand , and shifted to 37 Â°C for times indicated in the figures . Cells were 900 stained for EEA1 , followed by confocal microscopy to assess the arrival of ligand to the 901 early endosome . To assess fluid - phase uptake , Alexa 555 - conjugated dextran ( 0 . 2 902 mg / ml ) was added to complete medium and cells were incubated 37 Â°C for times 903 indicated in the figures . Cells were then stained for EEA1 , followed by confocal 904 microscopy to assess the arrival of this probe to the early endosome . 905 906 Confocal microscopy 907 Colocalization studies were performed with the Zeiss Axio Observer Z1 Inverted 908 Microscope having a Plan - Apochromat 63Ã— objective , the Zeiss LSM 800 with Airyscan 909 confocal package with Zeiss URGB ( 488 - and 561 - nm ) laser lines , and Zen 2 . 3 blue 910 edition confocal acquisition software . For quantification of colocalization , ten fields of 911 cells were examined , with each field typically containing about 5 cells . Images were 912 imported into the NIH ImageJ v . 1 . 50e software , and then analyzed through a plugin 913 software ( https : / / imagej . net / Coloc _ 2 ) . Under the â€˜imageâ€™ tab , the â€˜split channelsâ€™ option 914 was selected . Under the â€˜pluginsâ€™ tab , â€˜colocalization analysisâ€™ option was selected , and 915 within this option , the â€˜colocalization thresholdâ€™ option was selected . Menders Coefficient 916 was used for colocalization analysis . Colocalization values were calculated by the 917 software , and expressed as the fraction of protein of interest colocalized with EEA1 . 918 919 Synthesis of HA - Cy3 probe 920 Hyaluronic acid ( HA , 2 mg , Sigma 75044 , Lot # BCBM2884 ) was dissolved in a 1 : 1 921 solution of dimethylsulfoxide ( DMSO ) and water ( 0 . 4 mL ) for a stock concentration of 5 922 mg / mL . The polymer was sonicated under heating to ensure full solubilization . The HA 923 solution was then diluted into HEPES ( 50 mM final HEPES concentration for a total 924 reaction volume of 2 mL once all components are combined ) . Sulfo - Cyanine3 amine 925 ( 2 . 36 mg , Lumiprobe ) was separately dissolved in DMSO ( 0 . 236 mL ) for a stock 926 concentration of 10 mg / mL . N - ( 3 - Dimethylaminopropyl ) - Nâ€² - ethylcarbodiimide 927 hydrochloride ( EDC , 0 . 253 mg , Sigma ) was separately dissolved in 50 mM HEPES 928 ( 0 . 051 mL ) for a stock concentration of 5 mg / mL . The HA and EDC solutions were then 929 combined under stirring , followed by addition of the dye solution . The reaction was 930 stirred , protected from light , at room temperature for 12 h . Following , unreacted dye was 931 removed via Amicon Ultra - 0 . 5 Centrifugal Filters ( Millipore Sigma ) . Manufacturer 932 guidelines were followed to select purification spin speeds and times : 14000 rcf , 15 min 933 per wash step ( water ) until washes were clear and colorless . The purified HA - Cy3 probe 934 was stored in water at 4 Â°C until used . 935 936 Preparation of liposomes 937 Ether lipid liposomes were prepared as previously described 19 . C18 ( Plasm ) - 20 : 4PE 938 ( Catalog . no 852804 ) and C18 ( Plasm ) - 18 : 1PE ( Catalog . no . 852758 ) were purchased 939 from Avanti Polar Lipids Inc . 940 941 Characterization of liposomes 942 Table shows the hydrodynamic diameter and polydispersity of liposomes used in this 943 study . The average and standard deviation of three technical repeats is provided . A 944 Malvern ZS90 Particle Analyzer was used for size measurements reported . 945 Liposome Hydrodynamic diameter ( nm ) Polydispersity index C18 ( Plasm ) - 20 : 4 PE 174 . 8 Â± 2 . 25 0 . 273 Â± 0 . 01 C18 ( Plasm ) - 18 : 1 PE 128 . 7 Â± 2 . 07 0 . 287 Â± 0 . 03 946 Membrane tension 947 Tether pulling experiments were performed on a home - built optical trap , following 948 principles described elsewhere 65 , 96 . Briefly , 4 Âµm anti - Digoxigenin coated polystyrene 949 beads ( Spherotech ) were trapped with a 1064 nm , Ytterbium laser ( IPG Photonics ) 950 focused through a 60x 1 . 2 NA objective ( Olympus ) . Forces on the beads were 951 measured by the deflection of backscattered trapping laser light onto a lateral effect 952 position sensor ( Thorlabs ) and calibrated using the viscous drag method 97 . To measure 953 tether radii ( R ) , cell lines were transiently transfected with a membrane - targeted 954 fluorescent protein ( glycosylphosphatidylinositol - anchored eGFP , Addgene # 32601 ) 955 using a TransIT - X2 transfection kit ( Mirus ) . Tether radius was obtained by comparing 956 tether fluorescence to fluorescence counts from a known area of the parent cell 957 membrane , as described 48 . Tether force ( ð‘“ ) and fluorescence measurements were 958 performed simultaneously . Membrane tension was calculated using the following 959 equation : 960 961 Membrane tension , ðœŽ = ! " # $ 962 963 Ether lipid liposome reconstitution assays 964 Adherent cells were treated with ether lipid liposomes 16 - 18 h prior to performing 965 respective membrane tension or endocytosis assays . Lipid liposomes were added 966 directly to the culture medium for a final concentration of 20 ÂµM . Cells were switched 967 from liposome - containing media to " extracellular imaging buffer " ( HEPES buffer with 968 dextrose , NaCl , KCl , MgCl2 , CaCl2 ) during membrane tension experiments . 969 970 Miscibility transition temperatures ( T misc ) measurements 971 Miscibility transition temperatures ( T misc ) measurements were performed as previously 972 reported 98 , 99 . Briefly , cells were washed in PBS , and cell membranes were labeled with 973 5 Âµg / ml fluorescent disordered / nonraft phase marker FAST DiO ( Thermo Fisher 974 Scientific ) for 10 min on ice . Cells were then washed twice in GPMV buffer ( 10 mM 975 HEPES , 150 mM NaCl , 2 mM CaCl2 , pH 7 . 4 ) , and then incubated with GPMV buffer 976 supplemented with 25 mM paraformaldehyde ( PFA ) and 2 mM dithiothreitol ( DTT ) for 1 977 h at 37 Â°C . Vesicles were imaged at 40Ã— on an inverted epifluorescence microscope 978 ( Leica DMi8 ) under temperature - controlled conditions using a microscope stage 979 equipped with a Peltier element ( Warner Instruments ) . GPMVs were imaged from 4Â° C - 980 28 Â°C , counting phase - separated and uniform vesicles at each temperature . For each 981 temperature , 25 - 50 vesicles were counted and the percent of phase - separated vesicles 982 were calculated , plotted versus temperature , and a fitted to a sigmoidal curve to 983 determine the temperature at which 50 % of the vesicles were phase - separated ( T misc ) . 984 985 C - laurdan spectral imaging 986 C - Laurdan imaging was performed as previously described 98 - 102 . Briefly , cells were 987 washed with PBS and stained with 10 Âµg / mL C - Laurdan for 10 min on ice , then imaged 988 using confocal microscopy on a Leica SP8 with spectral imaging at 60Ã— ( water 989 immersion , NA = X ) and excitation at 405 nm . The emission was collected as two 990 images : 420 â€“ 460 nm and 470 â€“ 510 nm . MATLAB ( MathWorks , Natick , MA ) was used to 991 calculate the two - dimensional ( 2D ) GP map , where GP for each pixel was calculated as 992 previously described 102 . Briefly , each image was background subtracted and 993 thresholded to keep only pixels with intensities greater than 3 standard deviations of the 994 background value in both channels . The GP image was calculated for each pixel using 995 Eq . 1 . GP maps ( pixels represented by GP value rather than intensity ) were imported 996 into ImageJ . To calculate the average PM GP , line scans drawn across individual cells . 997 PM GP values were taken as peak GP values from the periphery of the cell , whereas 998 internal membranes were calculated as the average of all values outside the PM peak . 999 The average GP of the internal membranes was calculated by determining the average 1000 GP of all pixels in a mask drawn on each cell just inside of the PM . 1001 ðºð‘ƒ = âˆ‘ ð¼ % " & â€™ " ( â€™ âˆ’ âˆ‘ ð¼ % ) * â€™ " + â€™ âˆ‘ ð¼ % " & â€™ " ( â€™ + âˆ‘ ð¼ % ) * â€™ " + â€™ 1002 1003 Extravasation assay 1004 Cells and reagents : Immortalized human umbilical vein endothelial cells ( ECs ) 1005 expressing BFP 82 were cultured in VascuLife VEGF Endothelial Medium ( Lifeline Cell 1006 Technology ) . Normal human lung fibroblasts ( FBs ) ( Lonza , P7 ) were cultured in 1007 FibroLife S2 Fibroblast Medium ( Lifeline Cell Technology ) . 1008 1009 Microfluidic device : 3D cell culture chips ( AIM Biotech ) were used to generate in vitro 1010 microvascular networks ( MVNs ) . The AIM chip body was made of cyclic olefin polymer 1011 ( COP ) with a type of gas - permeable plastic serving as the bottom film . AIM Biotech 1012 chips contained three parallel channels : a central gel channel flanked by two media 1013 channels . Microposts separated fluidic channels and serve to confine the liquid gelling 1014 solution in the central channel by surface tension before polymerization . The gel 1015 channel was 1 . 3 mm wide and 0 . 25 mm tall , the gap between microposts was 0 . 1 mm , 1016 and the width of media channels was 0 . 5 mm . 1017 1018 Microvascular network formation : To generate perfusable MVNs , ECs and FBs were 1019 seeded into the microfluidic chip using a two - step method 103 . Briefly , ECs and FBs 1020 were concentrated in VascuLife containing thrombin ( 4 U / mL ) . For the first step seeding , 1021 the outer layer EC solution was made with a final concentration of 10 Ã—10 6 / mL . After 1022 mixed with fibrinogen ( 3 mg / mL final concentration ) at a 1 : 1 ratio , the outer layer EC 1023 solution was pipetted into the gel inlet , immediately followed by aspirating from the gel 1024 outlet , leaving only residual solution around the microposts . For the second step , 1025 another solution with final concentrations of 5 Ã—10 6 / mL ECs and 1 . 5 Ã—10 6 / mL fibroblasts 1026 was similarly mixed with fibrinogen and then pipetted into the same chip through the gel 1027 outlet . The device was placed upside down to polymerize in a humidiï¬ed enclosure and 1028 allowed to polymerize at 37 Â°C for 15 min in a 5 % CO 2 incubator . Next , VascuLife 1029 culture medium was added to the media channels and changed daily in the device . After 1030 7 days , MVNs were ready for further experiments . 1031 1032 Tumor cell perfusion in MVNs : 1099 or pB3 cell line derivatives expressing pCDH - EF1 - 1033 Luc2 - P2A - tdTomato ( Plasmid # 72486 , Addgene ) were resuspended at a concentration 1034 of 1Ã—10 6 / mL in culture medium . To perfuse these tumor cells into in vitro MVNs , the 1035 culture medium in one media channel was aspirated , followed by injection of a 20 ÂµL 1036 tumor cell suspension in the MVNs and repeated twice . Microfluidic devices were then 1037 placed at 37 Â°C for 15 min in a 5 % CO 2 incubator for 15 min . After that , the tumor cell 1038 medium was aspirated from the media channels to remove the unattached cells , and 1039 Vasculife was replenished . Devices were then placed back to the incubator . 24 h later , 1040 devices were fixed , washed , and imaged using an Olympus FLUOVIEW FV1200 1041 confocal laser scanning microscope with a 10 Â´ objective and an additional 2 Â´ zoom - in 1042 function . Z - stack images were acquired with a 5 Âµm step size . All images shown are 1043 collapsed Z - stacks , displayed using range - adjusted Imaris software , unless otherwise 1044 specified . Extravasation percentage was calculated by dividing the cell number of 1045 extravasated tumor cells with the total number of tumor cells in the same imaging region 1046 of interest . 1047 1048 Histology 1049 Harvested tissues were fixed by incubating with 10 % neural - buffered formalin ( VWR 1050 Scientific ) at 4 Â° C for 16 â€“ 18 h . Fixed samples were then transferred to 70 % ethanol and 1051 submitted to Hope Babette Tang Histology Facility at the Koch Institute at MIT for 1052 paraffin - embedding and H & E staining . Metastatic burden was quantified using QuPath 1053 software 104 and Image J 105 . 1054 1055 Statistical Analysis 1056 For statistical analyses , Mann - Whitney U test or unpaired , two - tailed t - test were 1057 performed using GraphPad Prism . 1058 1059 1060 Supplemental Data Fig . file S1 : Lipidomic analysis of ether lipid deficient cells 1061 1062 Correspondence and requests for materials should be addressed to Robert A . Weinberg 1063 ( weinberg @ wi . mit . edu ) . 1064 1065 REFERENCES 1066 1 . Levental , I . & Lyman , E . Regulation of membrane protein structure and function 1067 by their lipid nano - environment . Nat Rev Mol Cell Biol 24 , 107 - 122 ( 2023 ) . 1068 2 . Viswanathan , V . S . et al . Dependency of a therapy - resistant state of cancer cells 1069 on a lipid peroxidase pathway . Nature 547 , 453 - 457 ( 2017 ) . 1070 3 . Hangauer , M . J . et al . Drug - tolerant persister cancer cells are vulnerable to GPX4 1071 inhibition . Nature 551 , 247 - 250 ( 2017 ) . 1072 4 . Mai , T . T . et al . Salinomycin kills cancer stem cells by sequestering iron in 1073 lysosomes . Nat Chem 9 , 1025 - 1033 ( 2017 ) . 1074 5 . Stockwell , B . R . et al . Ferroptosis : A Regulated Cell Death Nexus Linking 1075 Metabolism , Redox Biology , and Disease . Cell 171 , 273 - 285 ( 2017 ) . 1076 6 . Yang , W . S . & Stockwell , B . R . Ferroptosis : Death by Lipid Peroxidation . Trends 1077 Cell Biol 26 , 165 - 176 ( 2016 ) . 1078 7 . Dixon , S . J . et al . Ferroptosis : an iron - dependent form of nonapoptotic cell death . 1079 Cell 149 , 1060 - 1072 ( 2012 ) . 1080 8 . Gupta , P . B . et al . Identification of selective inhibitors of cancer stem cells by high - 1081 throughput screening . Cell 138 , 645 - 659 ( 2009 ) . 1082 9 . Antoszczak , M . et al . Iron - Sensitive Prodrugs That Trigger Active Ferroptosis in 1083 Drug - Tolerant Pancreatic Cancer Cells . J Am Chem Soc 144 , 11536 - 11545 1084 ( 2022 ) . 1085 10 . Yang , W . S . et al . Regulation of ferroptotic cancer cell death by GPX4 . Cell 156 , 1086 317 - 331 ( 2014 ) . 1087 11 . Doll , S . et al . FSP1 is a glutathione - independent ferroptosis suppressor . Nature 1088 575 , 693 - 698 ( 2019 ) . 1089 12 . Bersuker , K . et al . The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit 1090 ferroptosis . Nature 575 , 688 - 692 ( 2019 ) . 1091 13 . Yang , W . S . & Stockwell , B . R . Synthetic lethal screening identifies compounds 1092 activating iron - dependent , nonapoptotic cell death in oncogenic - RAS - harboring 1093 cancer cells . Chem Biol 15 , 234 - 245 ( 2008 ) . 1094 14 . Dixon , S . J . et al . Pharmacological inhibition of cystine - glutamate exchange 1095 induces endoplasmic reticulum stress and ferroptosis . Elife 3 , e02523 ( 2014 ) . 1096 15 . Li , Q . et al . Inhibition of neuronal ferroptosis protects hemorrhagic brain . JCI 1097 Insight 2 , e90777 ( 2017 ) . 1098 16 . Fang , X . et al . Ferroptosis as a target for protection against cardiomyopathy . Proc 1099 Natl Acad Sci U S A 116 , 2672 - 2680 ( 2019 ) . 1100 17 . Yu , Y . et al . Hepatic transferrin plays a role in systemic iron homeostasis and liver 1101 ferroptosis . Blood 136 , 726 - 739 ( 2020 ) . 1102 18 . Friedmann Angeli , J . P . et al . Inactivation of the ferroptosis regulator Gpx4 triggers 1103 acute renal failure in mice . Nat Cell Biol 16 , 1180 - 1191 ( 2014 ) . 1104 19 . Zou , Y . et al . Plasticity of ether lipids promotes ferroptosis susceptibility and 1105 evasion . Nature ( 2020 ) . 1106 20 . Dean , J . M . & Lodhi , I . J . Structural and functional roles of ether lipids . Protein Cell 1107 9 , 196 - 206 ( 2018 ) . 1108 21 . Benjamin , D . I . et al . Ether lipid generating enzyme AGPS alters the balance of 1109 structural and signaling lipids to fuel cancer pathogenicity . Proc Natl Acad Sci U 1110 S A 110 , 14912 - 14917 ( 2013 ) . 1111 22 . Snyder , F . & Wood , R . Alkyl and alk - 1 - enyl ethers of glycerol in lipids from normal 1112 and neoplastic human tissues . Cancer Res 29 , 251 - 257 ( 1969 ) . 1113 23 . Albert , D . H . & Anderson , C . E . Ether - linked glycerolipids in human brain tumors . 1114 Lipids 12 , 188 - 192 ( 1977 ) . 1115 24 . Snyder , F . , Blank , M . L . & Morris , H . P . Occurrence and nature of O - alkyl and O - 1116 alk - I - enyl moieties of glycerol in lipids of Morris transplanted hepatomas and 1117 normal rat liver . Biochim Biophys Acta 176 , 502 - 510 ( 1969 ) . 1118 25 . Cui , W . , Liu , D . , Gu , W . & Chu , B . Peroxisome - driven ether - linked phospholipids 1119 biosynthesis is essential for ferroptosis . Cell Death Differ 28 , 2536 - 2551 ( 2021 ) . 1120 26 . Saxena , M . , Kalathur , R . K . R . , Neutzner , M . & Christofori , G . PyMT - 1099 , a 1121 versatile murine cell model for EMT in breast cancer . Sci Rep 8 , 12123 ( 2018 ) . 1122 27 . Doll , S . et al . ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid 1123 composition . Nat Chem Biol 13 , 91 - 98 ( 2017 ) . 1124 28 . Kagan , V . E . et al . Oxidized arachidonic and adrenic PEs navigate cells to 1125 ferroptosis . Nat Chem Biol 13 , 81 - 90 ( 2017 ) . 1126 29 . Ye , X . et al . Distinct EMT programs control normal mammary stem cells and 1127 tumour - initiating cells . Nature 525 , 256 - 260 ( 2015 ) . 1128 30 . Pantopoulos , K . , Porwal , S . K . , Tartakoff , A . & Devireddy , L . Mechanisms of 1129 mammalian iron homeostasis . Biochemistry 51 , 5705 - 5724 ( 2012 ) . 1130 31 . Muckenthaler , M . U . , Rivella , S . , Hentze , M . W . & Galy , B . A Red Carpet for Iron 1131 Metabolism . Cell 168 , 344 - 361 ( 2017 ) . 1132 32 . Muller , S . et al . CD44 regulates epigenetic plasticity by mediating iron 1133 endocytosis . Nat Chem 12 , 929 - 938 ( 2020 ) . 1134 33 . Niwa , M . , Hirayama , T . , Okuda , K . & Nagasawa , H . A new class of high - contrast 1135 Fe ( II ) selective fluorescent probes based on spirocyclized scaffolds for 1136 visualization of intracellular labile iron delivered by transferrin . Org Biomol Chem 1137 12 , 6590 - 6597 ( 2014 ) . 1138 34 . Houk , R . S . Mass spectrometry of inductively coupled plasmas . Analytical 1139 Chemistry 58 , 97A - 105A ( 1986 ) . 1140 35 . Figueroa , J . A . , Stiner , C . A . , Radzyukevich , T . L . & Heiny , J . A . Metal ion transport 1141 quantified by ICP - MS in intact cells . Sci Rep 6 , 20551 ( 2016 ) . 1142 36 . Hoepken , H . H . , Korten , T . , Robinson , S . R . & Dringen , R . Iron accumulation , iron - 1143 mediated toxicity and altered levels of ferritin and transferrin receptor in cultured 1144 astrocytes during incubation with ferric ammonium citrate . J Neurochem 88 , 1145 1194 - 1202 ( 2004 ) . 1146 37 . Bauckman , K . A . , Haller , E . , Flores , I . & Nanjundan , M . Iron modulates cell 1147 survival in a Ras - and MAPK - dependent manner in ovarian cells . Cell Death Dis 1148 4 , e592 ( 2013 ) . 1149 38 . Gammella , E . , Buratti , P . , Cairo , G . & Recalcati , S . The transferrin receptor : the 1150 cellular iron gate . Metallomics 9 , 1367 - 1375 ( 2017 ) . 1151 39 . Al - Hajj , M . , Wicha , M . S . , Benito - Hernandez , A . , Morrison , S . J . & Clarke , M . F . 1152 Prospective identification of tumorigenic breast cancer cells . Proc Natl Acad Sci 1153 U S A 100 , 3983 - 3988 ( 2003 ) . 1154 40 . Yan , Y . , Zuo , X . & Wei , D . Concise Review : Emerging Role of CD44 in Cancer 1155 Stem Cells : A Promising Biomarker and Therapeutic Target . Stem Cells Transl 1156 Med 4 , 1033 - 1043 ( 2015 ) . 1157 41 . Solier , S . et al . A druggable copper - signalling pathway that drives inflammation . 1158 Nature 617 , 386 - 394 ( 2023 ) . 1159 42 . Aruffo , A . , Stamenkovic , I . , Melnick , M . , Underhill , C . B . & Seed , B . CD44 is the 1160 principal cell surface receptor for hyaluronate . Cell 61 , 1303 - 1313 ( 1990 ) . 1161 43 . Hua , Q . , Knudson , C . B . & Knudson , W . Internalization of hyaluronan by 1162 chondrocytes occurs via receptor - mediated endocytosis . J Cell Sci 106 ( Pt 1 ) , 1163 365 - 375 ( 1993 ) . 1164 44 . Bendris , N . et al . SNX9 promotes metastasis by enhancing cancer cell invasion 1165 via differential regulation of RhoGTPases . Mol Biol Cell ( 2016 ) . 1166 45 . Thottacherry , J . J . , Sathe , M . , Prabhakara , C . & Mayor , S . Spoiled for Choice : 1167 Diverse Endocytic Pathways Function at the Cell Surface . Annu Rev Cell Dev 1168 Biol 35 , 55 - 84 ( 2019 ) . 1169 46 . Saric , A . & Freeman , S . A . Endomembrane Tension and Trafficking . Front Cell 1170 Dev Biol 8 , 611326 ( 2020 ) . 1171 47 . McMahon , H . T . & Boucrot , E . Molecular mechanism and physiological functions 1172 of clathrin - mediated endocytosis . Nat Rev Mol Cell Biol 12 , 517 - 533 ( 2011 ) . 1173 48 . Pinot , M . et al . Lipid cell biology . Polyunsaturated phospholipids facilitate 1174 membrane deformation and fission by endocytic proteins . Science 345 , 693 - 697 1175 ( 2014 ) . 1176 49 . Howes , M . T . et al . Clathrin - independent carriers form a high capacity endocytic 1177 sorting system at the leading edge of migrating cells . J Cell Biol 190 , 675 - 691 1178 ( 2010 ) . 1179 50 . Lakshminarayan , R . et al . Galectin - 3 drives glycosphingolipid - dependent 1180 biogenesis of clathrin - independent carriers . Nat Cell Biol 16 , 595 - 606 ( 2014 ) . 1181 51 . Galbiati , F . , Razani , B . & Lisanti , M . P . Emerging themes in lipid rafts and 1182 caveolae . Cell 106 , 403 - 411 ( 2001 ) . 1183 52 . Doherty , G . J . & McMahon , H . T . Mechanisms of endocytosis . Annu Rev Biochem 1184 78 , 857 - 902 ( 2009 ) . 1185 53 . Boucrot , E . et al . Endophilin marks and controls a clathrin - independent endocytic 1186 pathway . Nature 517 , 460 - 465 ( 2015 ) . 1187 54 . Holst , M . R . et al . Clathrin - Independent Endocytosis Suppresses Cancer Cell 1188 Blebbing and Invasion . Cell Rep 20 , 1893 - 1905 ( 2017 ) . 1189 55 . Thottacherry , J . J . et al . Mechanochemical feedback control of dynamin 1190 independent endocytosis modulates membrane tension in adherent cells . Nat 1191 Commun 9 , 4217 ( 2018 ) . 1192 56 . Baba , T . et al . Clathrin - dependent and clathrin - independent endocytosis are 1193 differentially sensitive to insertion of poly ( ethylene glycol ) - derivatized cholesterol 1194 in the plasma membrane . Traffic 2 , 501 - 512 ( 2001 ) . 1195 57 . Kozlov , M . M . & Chernomordik , L . V . Membrane tension and membrane fusion . 1196 Curr Opin Struct Biol 33 , 61 - 67 ( 2015 ) . 1197 58 . Sitarska , E . & Diz - Munoz , A . Pay attention to membrane tension : 1198 Mechanobiology of the cell surface . Curr Opin Cell Biol 66 , 11 - 18 ( 2020 ) . 1199 59 . Wu , X . S . et al . Membrane Tension Inhibits Rapid and Slow Endocytosis in 1200 Secretory Cells . Biophys J 113 , 2406 - 2414 ( 2017 ) . 1201 60 . Gottlieb , T . A . , Ivanov , I . E . , Adesnik , M . & Sabatini , D . D . Actin microfilaments play 1202 a critical role in endocytosis at the apical but not the basolateral surface of 1203 polarized epithelial cells . J Cell Biol 120 , 695 - 710 ( 1993 ) . 1204 61 . Dai , J . & Sheetz , M . P . Regulation of endocytosis , exocytosis , and shape by 1205 membrane tension . Cold Spring Harb Symp Quant Biol 60 , 567 - 571 ( 1995 ) . 1206 62 . Hirama , T . et al . Membrane curvature induced by proximity of anionic 1207 phospholipids can initiate endocytosis . Nat Commun 8 , 1393 ( 2017 ) . 1208 63 . Loh , J . et al . An acute decrease in plasma membrane tension induces 1209 macropinocytosis via PLD2 activation . J Cell Sci 132 ( 2019 ) . 1210 64 . Bucher , D . et al . Clathrin - adaptor ratio and membrane tension regulate the flat - to - 1211 curved transition of the clathrin coat during endocytosis . Nat Commun 9 , 1109 1212 ( 2018 ) . 1213 65 . Dai , J . & Sheetz , M . P . Mechanical properties of neuronal growth cone 1214 membranes studied by tether formation with laser optical tweezers . Biophys J 68 , 1215 988 - 996 ( 1995 ) . 1216 66 . Levental , K . R . et al . Lipidomic and biophysical homeostasis of mammalian 1217 membranes counteracts dietary lipid perturbations to maintain cellular fitness . 1218 Nat Commun 11 , 1339 ( 2020 ) . 1219 67 . Halbleib , K . et al . Activation of the Unfolded Protein Response by Lipid Bilayer 1220 Stress . Mol Cell 67 , 673 - 684 e678 ( 2017 ) . 1221 68 . Ernst , R . , Ejsing , C . S . & Antonny , B . Homeoviscous Adaptation and the 1222 Regulation of Membrane Lipids . J Mol Biol 428 , 4776 - 4791 ( 2016 ) . 1223 69 . Levitan , I . Evaluating membrane structure by Laurdan imaging : Disruption of lipid 1224 packing by oxidized lipids . Curr Top Membr 88 , 235 - 256 ( 2021 ) . 1225 70 . Veatch , S . L . et al . Critical fluctuations in plasma membrane vesicles . ACS Chem 1226 Biol 3 , 287 - 293 ( 2008 ) . 1227 71 . Thankamony , S . P . & Knudson , W . Acylation of CD44 and its association with lipid 1228 rafts are required for receptor and hyaluronan endocytosis . J Biol Chem 281 , 1229 34601 - 34609 ( 2006 ) . 1230 72 . Li , P . et al . The iron chelator Dp44mT suppresses osteosarcoma ' s proliferation , 1231 invasion and migration : in vitro and in vivo . Am J Transl Res 8 , 5370 - 5385 1232 ( 2016 ) . 1233 73 . Basuli , D . et al . Iron addiction : a novel therapeutic target in ovarian cancer . 1234 Oncogene 36 , 4089 - 4099 ( 2017 ) . 1235 74 . Guo , W . et al . An important role of the hepcidin - ferroportin signaling in affecting 1236 tumor growth and metastasis . Acta Biochim Biophys Sin ( Shanghai ) 47 , 703 - 715 1237 ( 2015 ) . 1238 75 . Chi , Y . et al . Cancer cells deploy lipocalin - 2 to collect limiting iron in 1239 leptomeningeal metastasis . Science 369 , 276 - 282 ( 2020 ) . 1240 76 . Tsujita , K . et al . Homeostatic membrane tension constrains cancer cell 1241 dissemination by counteracting BAR protein assembly . Nat Commun 12 , 5930 1242 ( 2021 ) . 1243 77 . Lambert , A . W . , Pattabiraman , D . R . & Weinberg , R . A . Emerging Biological 1244 Principles of Metastasis . Cell 168 , 670 - 691 ( 2017 ) . 1245 78 . Chen , M . B . et al . On - chip human microvasculature assay for visualization and 1246 quantification of tumor cell extravasation dynamics . Nat Protoc 12 , 865 - 880 1247 ( 2017 ) . 1248 79 . Chen , M . B . , Whisler , J . A . , Jeon , J . S . & Kamm , R . D . Mechanisms of tumor cell 1249 extravasation in an in vitro microvascular network platform . Integr Biol ( Camb ) 5 , 1250 1262 - 1271 ( 2013 ) . 1251 80 . Frose , J . et al . Epithelial - Mesenchymal Transition Induces Podocalyxin to 1252 Promote Extravasation via Ezrin Signaling . Cell Rep 24 , 962 - 972 ( 2018 ) . 1253 81 . Chen , M . B . , Lamar , J . M . , Li , R . , Hynes , R . O . & Kamm , R . D . Elucidation of the 1254 Roles of Tumor Integrin beta1 in the Extravasation Stage of the Metastasis 1255 Cascade . Cancer Res 76 , 2513 - 2524 ( 2016 ) . 1256 82 . Wan , Z . et al . A robust vasculogenic microfluidic model using human 1257 immortalized endothelial cells and Thy1 positive fibroblasts . Biomaterials 276 , 1258 121032 ( 2021 ) . 1259 83 . Prince , M . E . et al . Identification of a subpopulation of cells with cancer stem cell 1260 properties in head and neck squamous cell carcinoma . Proc Natl Acad Sci U S A 1261 104 , 973 - 978 ( 2007 ) . 1262 84 . Lambert , A . W . et al . DeltaNp63 / p73 drive metastatic colonization by controlling a 1263 regenerative epithelial stem cell program in quasi - mesenchymal cancer stem 1264 cells . Dev Cell 57 , 2714 - 2730 e2718 ( 2022 ) . 1265 85 . Fruman , D . A . , Meyers , R . E . & Cantley , L . C . Phosphoinositide kinases . Annu Rev 1266 Biochem 67 , 481 - 507 ( 1998 ) . 1267 86 . Rodriguez , R . , Schreiber , S . L . & Conrad , M . Persister cancer cells : Iron addiction 1268 and vulnerability to ferroptosis . Mol Cell ( 2021 ) . 1269 87 . Suzuki , T . et al . Crucial role of iron in epigenetic rewriting during adipocyte 1270 differentiation mediated by JMJD1A and TET2 activity . Nucleic Acids Res ( 2023 ) . 1271 88 . Herr , C . Q . & Hausinger , R . P . Amazing Diversity in Biochemical Roles of Fe ( II ) / 2 - 1272 Oxoglutarate Oxygenases . Trends Biochem Sci 43 , 517 - 532 ( 2018 ) . 1273 89 . Dongre , A . et al . Epithelial - to - Mesenchymal Transition Contributes to 1274 Immunosuppression in Breast Carcinomas . Cancer Res 77 , 3982 - 3989 ( 2017 ) . 1275 90 . Surma , M . A . et al . Mouse lipidomics reveals inherent flexibility of a mammalian 1276 lipidome . Sci Rep 11 , 19364 ( 2021 ) . 1277 91 . Ejsing , C . S . et al . Global analysis of the yeast lipidome by quantitative shotgun 1278 mass spectrometry . Proc Natl Acad Sci U S A 106 , 2136 - 2141 ( 2009 ) . 1279 92 . Surma , M . A . et al . An automated shotgun lipidomics platform for high throughput , 1280 comprehensive , and quantitative analysis of blood plasma intact lipids . Eur J 1281 Lipid Sci Technol 117 , 1540 - 1549 ( 2015 ) . 1282 93 . Herzog , R . et al . A novel informatics concept for high - throughput shotgun 1283 lipidomics based on the molecular fragmentation query language . Genome Biol 1284 12 , R8 ( 2011 ) . 1285 94 . Herzog , R . et al . LipidXplorer : a software for consensual cross - platform 1286 lipidomics . PLoS One 7 , e29851 ( 2012 ) . 1287 95 . Sampaio , J . L . et al . Membrane lipidome of an epithelial cell line . Proc Natl Acad 1288 Sci U S A 108 , 1903 - 1907 ( 2011 ) . 1289 96 . Ashkin , A . Acceleration and Trapping of Particles by Radiation Pressure . Physical 1290 Review Letters 24 , 156 - 159 ( 1970 ) . 1291 97 . Kuo , S . C . & Sheetz , M . P . Optical tweezers in cell biology . Trends Cell Biol 2 , 116 - 1292 118 ( 1992 ) . 1293 98 . Levental , K . R . & Levental , I . Isolation of giant plasma membrane vesicles for 1294 evaluation of plasma membrane structure and protein partitioning . Methods Mol 1295 Biol 1232 , 65 - 77 ( 2015 ) . 1296 99 . Sezgin , E . et al . Elucidating membrane structure and protein behavior using giant 1297 plasma membrane vesicles . Nat Protoc 7 , 1042 - 1051 ( 2012 ) . 1298 100 . Levental , K . R . et al . Polyunsaturated lipids regulate membrane domain stability 1299 by tuning membrane order . Biophys J 110 ( 8 ) , 1800 - 1810 ( 2016 ) . 1300 101 . Levental , K . R . et al . omega - 3 polyunsaturated fatty acids direct differentiation of 1301 the membrane phenotype in mesenchymal stem cells to potentiate osteogenesis . 1302 Sci Adv 3 , eaao1193 ( 2017 ) . 1303 102 . Sezgin , E . , Waithe , D . , Bernardino de la Serna , J . & Eggeling , C . Spectral 1304 imaging to measure heterogeneity in membrane lipid packing . Chemphyschem 1305 16 , 1387 - 1394 ( 2015 ) . 1306 103 . Wan , Z . et al . A Robust Method for Perfusable Microvascular Network Formation 1307 In Vitro . Small Methods 6 , e2200143 ( 2022 ) . 1308 104 . Bankhead , P . et al . QuPath : Open source software for digital pathology image 1309 analysis . Sci Rep 7 , 16878 ( 2017 ) . 1310 105 . Schneider , C . A . , Rasband , W . S . & Eliceiri , K . W . NIH Image to ImageJ : 25 years 1311 of image analysis . Nat Methods 9 , 671 - 675 ( 2012 ) . 1312 1313 W T A G P S K O A G P S A ddba c k 0 . 00 0 . 05 0 . 10 0 . 15 M o l % o f t o t a l li p i d s PE 18 : 2 _ 20 : 3 p = 0 . 0002 p < 0 . 0001 W T A G P S K O A G P S A ddba c k 0 . 00 0 . 05 0 . 10 0 . 15 M o l % o f t o t a l li p i d s PE 18 : 0 _ 22 : 3 p < 0 . 0001 p = 0 . 0005 - 10 - 5 0 5 10 0 2 4 6 8 10 Log 2 FC ( AGPS KO / WT ) - Log 10 p v a l ue pB3 PE 18 : 0 _ 22 : 3 PE 18 : 2 _ 20 : 3 PE 18 : 1 _ 20 : 5 PE 18 : 1 _ 22 : 5 PE 18 : 2 _ 20 : 4 Ether lipids Non - ether PUFA - PLs Other lipids - 10 - 5 0 5 10 0 3 6 9 12 Log 2 FC ( AGPS KO / WT ) - Log 10 p v a l ue PE 18 : 0 _ 22 : 5 PE 18 : 1 _ 20 : 4 PE 16 : 0 _ 22 : 6 PE 18 : 2 _ 20 : 4 PE 16 : 1 _ 22 : 6 Ether lipids Non - ether PUFA - PLs Other lipids PyMT - 1099 TGF - Î² 0 1 Ã— 10 4 2 Ã— 10 4 3 Ã— 10 4 4 Ã— 10 4 5 Ã— 10 4 p m o l Oxi . ( PE ) Ether - PLs ML210 - + - + Oxi . ( PE ) Ester - PLs PyMT - 1099 TGF - Î² 0 10 20 30 R e l a t i v e e t he r li p i d l e v e l s ( M o l % o f t o t a l li p i d s ) PyMT - 1099 TGF - Î² TGF - Î² WT AGPS KO - - + + p < 0 . 0001 p < 0 . 0001 W T A G P S K O A G P S A ddba c k 0 . 00 0 . 02 0 . 04 0 . 06 0 . 08 M o l % o f t o t a l li p i d s PE 18 : 2 _ 20 : 4 p = 0 . 0002 p = 0 . 0002 W T A G P S K O A G P S A ddba c k 0 . 00 0 . 05 0 . 10 0 . 15 0 . 20 M o l % o f t o t a l li p i d s PE 18 : 1 _ 20 : 5 p < 0 . 0001 p < 0 . 0001 W T A G P S K O A G P S A ddba c k 0 10 20 30 pB3 R e l a t i v e e t he r li p i d l e v e l s ( M o l % o f t o t a l li p i d s ) p < 0 . 0001 p < 0 . 0001 0 . 0 0 . 5 1 . 0 1 . 5 2 . 0 2 . 5 0 25 50 75 [ ML210 ] , Âµ M % V i ab ili t y WTWT + TGF - Î² 125 100 AGPS KO AGPS KO + TGF - Î² Fig . 1 Ether lipid Compositon 012 â‰¥ 3 Total no . of double bonds a d e f g h i j b c W T A G P S K O A G P S A dd ba ck 0 1 2 3 F o l d c hange L ys o s o m a l F e ( II ) p = 0 . 0016 p = 0 . 0236 ns 0 20 40 60 F e pe r 1 x 10 6 c e ll s ( ng ) - - + + TGF - Î² WT AGPS KO p < 0 . 0001 p = 0 . 0049 p = 0 . 0018 0 1 2 3 F o l d c hange L ys o s o m a l F e ( II ) p = 0 . 0133 p = 0 . 0022 p = 0 . 0005 - - + + TGF - Î² WT AGPS KO W T A G P S K O A G P S A ddba ck 0 50 100 150 F e i n ng / m g t i ss ue ( d r y w e i gh t ) p = 0 . 0331 ns p = 0 . 0184 W T A G P S K O A G P S A ddba ck 0 5 10 15 20 25 F e pe r 1 x 10 6 c e ll s ( ng ) p = 0 . 0082 p = 0 . 0023 ns - 1 . 0 - 0 . 5 0 . 0 0 . 5 0 50 100 150 Log 10 ( ML210 ) , Âµ M % V i ab ili t y Ctrl ( - TGF - Î² ) no FAC Ctrl ( + TGF - Î² ) no FAC AGPS KO ( - TGF - Î² ) no FAC AGPS KO ( + TGF - Î² ) no FAC AGPS KO ( + TGF - Î² ) FAC AGPS KO ( + TGF - Î² ) FAC + Liproxstatin - 1 N T s g A G P S K O F A R 1 K O A G P S K O + F A C 0 5 10 15 20 F e pe r 1 x 10 6 c e ll s ( ng ) p = 0 . 0055 p = 0 . 0022 ns p = 0 . 0016 N T s g A G P S K O F A R 1 K O A G P S K O + F A C 0 . 0 0 . 5 1 . 0 1 . 5 2 . 0 F o l d c hange L ys o s o m a l F e ( II ) p = 0 . 0005 p < 0 . 0001 ns p = 0 . 0094 - 2 - 1 0 1 0 25 50 75 100 125 Log 10 ( ML210 ) , Âµ M % V i ab ili t y NT sg AGPS KO no FAC AGPS KO + FAC AGPS KO + FAC + Liproxstatin - 1 FAR1 KO no FAC a b c d e f g h i Fig . 2 0 50 100 150 200 F e pe r 1 x 10 6 c e ll s ( ng ) HyaluronateHyaluronidase - - + - + - - - + - + - - - - + - + - WT ( untreated ) CD44 KO + TGF - Î² Ctrl ( WT ) + TGF - Î² CD44 KO ( untreated ) - + - + - p = 0 . 0028 p = 0 . 0037 nsns p = 0 . 0028 0 20 40 60 0 5 10 15 20 Time ( min ) H y a l u r ona t e p r obe c o l o c a li z ed w i t h EEA 1 ( % ) WT WT + TGF - Î² AGPS KO AGPS KO + TGF - Î² p = 0 . 001 0 p < 0 . 0001 0 5 10 15 20 25 0 5 10 15 20 25 Time ( min ) D e x t r an c o l o c a li z a t i on w i t h EEA 1 ( % ) WT WT + TGF - AGPS KO AGPS KO + TGF - p = 0 . 0023 0 2 4 6 0 10 20 30 40 Time ( min ) E G F c o l o c a li z a t i on w i t h EEA 1 ( % ) WT WT + TGF - Î² AGPS KO AGPS KO + TGF - Î² EGF : 2 ng / ml ( Low ) 0 2 4 6 0 10 20 30 Time ( min ) T r an s f e rr i n c o l o c a li z a t i on w i t h EEA 1 ( % ) WT WT + TGF - Î² AGPS KO AGPS KO + TGF - Î² ns ns 0 5 10 15 20 0 10 20 30 Time ( min ) D e x t r an c o l o c a li z ed w i t h EEA 1 ( % ) AGPS Addback AGPS KO WT p = 0 . 0061 p < 0 . 0001 0 20 40 60 0 5 10 15 20 Time ( min ) H y a l u r ona t e p r obe c o l o c a li z ed w i t h EEA 1 ( % ) AGPS Addback AGPS KO WT p < 0 . 0001 p < 0 . 0001 n s p < 0 . 0001 0 1 2 3 4 5 0 10 20 30 Time ( min ) T r an s f e rr i n c o l o c a li z ed w i t h EEA 1 ( % ) AGPS Addback AGPS KO WT a b c Fig . 3 d e f g h - 0 . 4 - 0 . 3 - 0 . 2 - 0 . 1 0 . 0 G P ( C - l au , i n t r a c e ll u l a r m e m b r ane s ) - - + + TGF - Î² WT AGPS KO p = 0 . 0004 p = 0 . 0058 ns 0 10 20 30 40 50 60 0 10 20 30 Time ( min ) H y a l u r ona t e p r obe c o l o c a li z ed w i t h EEA 1 ( % ) WTAGPS KO AGPS KO + PE ( 18 : 1p _ 18 : 0 ) AGPS KO + PE ( 18 : 1p _ 20 : 4 ) p < 0 . 0001 p < 0 . 0001 0 2 4 6 0 10 20 30 Time ( min ) T r an s f e rr i n c o l o c a li z ed w i t h EEA 1 ( % ) WTAGPS KO AGPS KO + PE ( 18 : 1p _ 18 : 0 ) AGPS KO + PE ( 18 : 1p _ 20 : 4 ) W T A G P S K O A G P S A ddba ck - 0 . 4 - 0 . 3 - 0 . 2 - 0 . 1 0 . 0 G P ( C - l au , i n t r a c e ll u l a r m e m b r ane s ) p = 0 . 0013 p = 0 . 0002 ns W T A G P S K O A G P S A ddba ck 0 . 0 0 . 2 0 . 4 0 . 6 0 . 8 G P ( C - l au , p l a s m a m e m b r ane s ) p = 0 . 0031 p = 0 . 0012 ns 5 10 15 20 25 30 35 10 20 30 40 50 60 70 80 90 Tether force ( pN ) T e t he r r ad i u s ( n m ) WTAGPS KO AGPS Addback a b c d e f 0 10 20 30 0 50 100 Temperature ( Â°C ) P ha s e s e pa r a t ed G P M V ( % ) WT AGPS KO g i h W T A G P S K O 8 10 12 14 16 T m i sc ( Â° C ) p = 0 . 0206 W T A G P S K O A G P S A ddba ck P E ( 18 : 1p _ 18 : 0 ) P E ( 18 : 1p _ 20 : 4 ) 0 . 00 0 . 05 0 . 10 0 . 15 0 . 20 0 . 25 M e m b r ane t en s i on ( p N / n m ) p = 0 . 0002 p = 0 . 0012 ns ns p = 0 . 0324 AGPS KO Fig . 4 W T A G P S K O 0 25 50 75 100 8000 10000 12000 14000 E s t i m a t ed nu m be r o f C S C s pe r 10 , 000 c e ll s p = 0 . 0119 W T A G P S K O T o t a l F l u x [ p / s ] , x 10 6 p = 0 . 0159 Dorsal 2 4 6 8 W T A G P S K O T o t a l F l u x [ p / s ] , x 10 7 p = 0 . 0159 Ventral 2 1 3 4 0 5 Fig . 5 a WT AGPS KO 100Âµm p = 0 . 0003 0 20 40 60 80 % E x t r a v a s a t i on - - + + TGF - Î² Ctrl AGPS KO p = 0 . 0030 ns W T A G P S K O 0 2 4 6 8 T u m o r W e i gh t ( g ) ns Ventral W T A G PS K O Radiance ( p / sec / cm 2 / sr ) x10 6 Color Scale Min = 3 . 05e4 Max = 1 . 01e6 1 . 0 0 . 8 0 . 6 0 . 4 0 . 2 Dorsal W T A G PS K O Radiance ( p / sec / cm 2 / sr ) x10 5 Color Scale Min = 1 . 42e4 Max = 1 . 90e5 1 . 5 0 . 5 1 . 0 WT AGPS KO WT AGPS KO Ctrl Untreated Ctrl + TGF - Î² AGPS KO + TGF - Î² C t r l C t r l + T G F - Î² A G P S K O + T G F - Î² 0 20 40 60 80 100 N o . o f l u ng m e t a s t a s e s p = 0 . 0186 p = 0 . 0084 ns b c d W T A G P S K O 0 10 20 30 40 % E x t r a v a s a t i on p = 0 . 0070 e 0 7 14 21 28 35 0 10 20 30 Days post - injection T u m o r D i a m e t e r , mm WTAGPS KO No . of mice with primary tumors Ctrl 3 / 8 Ctrl + TGF - Î² 8 / 8 AGPS KO + TGF - Î² 3 / 8 f h g i j k l m Extended Data Fig . 1 0 . 0 0 . 1 0 . 2 0 . 3 0 . 4 0 . 5 0 25 50 75 100 125 [ RSL3 ] , Âµ M % V i ab ili t y WTWT + TGF - Î² AGPS KO AGPS KO + TGF - Î² 0 1 Ã— 10 4 2 Ã— 10 4 3 Ã— 10 4 4 Ã— 10 4 5 Ã— 10 4 p m o l RSL3 - - + + Oxi . ( PE ) Ether - PLs Oxi . ( PE ) Ester - PLs pB3 a Agps Gapdh E - cadherin Zeb1 Vimentin Snail p B 2 W T A G PS K O A G PS A ddba ck pB3 b c d Extended Data Fig . 2 a b W T A G P S K O 0 10 20 30 F e pe r 1 x 10 6 c e ll s ( ng ) p = 0 . 0088 Far1 Gapdh Agps N T s g A G PS K O F A R 1 K O Extended Data Fig . 3 a b 0 10 20 30 40 50 F e pe r 1 x 10 6 c e ll s ( ng ) WT CD44 KO Hyaluronate Hyaluronidase - + + - - - - + + - - - p = 0 . 0118 p = 0 . 0102 Ovcar8 p = 0 . 0026 nsns 0 2 4 6 0 10 20 30 40 50 Time ( min ) E G F c o l o c a li z a t i on w i t h EEA 1 ( % ) WT WT + TGF - Î² AGPS KO AGPS KO + TGF - Î² EGF : 200 ng / ml ( High ) Extended Data Fig . 4 N T s g A G PS K O F A R K O a No . of cells implanted 100 1 , 000 10 , 000 100 , 000 WT 3 / 3 3 / 3 3 / 3 3 / 3 AGPS KO 0 / 3 3 / 3 3 / 3 3 / 3 W T CD 44 K O Radiance ( p / sec / cm 2 / sr ) Color Scale Min = 1 . 32e5 Max = 4 . 88e6 x10 6 1 . 0 2 . 0 3 . 0 4 . 0 Ventral 1 . 0 2 . 0 3 . 0 4 . 0 Radiance ( p / sec / cm 2 / sr ) Color Scale Min = 9 . 00e4 Max = 4 . 00e6 Dorsal W T CD 44 K O x10 6 WT CD44 KO 0 . 0 5 . 0 Ã— 10 7 1 . 0 Ã— 10 8 1 . 5 Ã— 10 8 2 . 0 Ã— 10 8 V en t r a l T o t a l f l u x [ p / s ] p = 0 . 0303 WT CD44 KO 0 . 0 2 . 0 Ã— 10 7 4 . 0 Ã— 10 7 6 . 0 Ã— 10 7 D o r s a l T o t a l f l u x [ p / s ] p = 0 . 0303 b c d